3rd Quarter Results

Barclays PLC
24 October 2023
 

Barclays PLC

 

Q3 2023 Results Announcement

 

30 September 2023

 

Notes

 

This document contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended).

 

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the nine months ended 30 September 2023 to the corresponding nine months of 2022 and balance sheet analysis as at 30 September 2023 with comparatives relating to 31 December 2022 and 30 September 2022. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

 

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

 

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.

 

The information in this announcement, which was approved by the Board of Directors on 23 October 2023, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2022, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

 

These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC's website at www.sec.gov.

 

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

 

Non-IFRS performance measures

 

Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 40 to 46 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

 

Forward-looking statements

 

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend policy and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings and regulatory investigations; the policies and actions of governmental and regulatory authorities; the Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and incidents and similar events beyond the Group's control; the impact of competition; capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine war on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK's exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and any disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group's reputation, business or operations; the Group's ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group's control. As a result, the Group's actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in Barclays PLC's filings with the US Securities and Exchange Commission (SEC) (including, without limitation, Barclays PLC's Annual Report on Form 20-F for the financial year ended 31 December 2022 and Interim Results Announcement for the six months ended 30 June 2023 filed on Form 6-K), which are available on the SEC's website at www.sec.gov.

 

Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Performance Highlights

 

Barclays delivered return on tangible equity (RoTE) of 11.0% in Q323 and 12.5% in Q323 YTD

 

C. S. Venkatakrishnan, Group Chief Executive, commented

"We delivered an 11.0% RoTE in Q3, against a mixed market backdrop, as we continued to manage credit well, remained disciplined on costs and maintained a strong capital position, with a Common Equity Tier 1 (CET1) ratio of 14.0%. We see further opportunities to enhance returns for shareholders through cost efficiencies and disciplined capital allocation across the Group. We will provide an Investor Update at FY23 results which will include setting out our capital allocation priorities, as well as revised financial targets"

 

 

 Q323 Group RoTE of 11.0% and Q323 YTD of 12.5%. Barclays UK Q323 RoTE of 21.0% and Q323 YTD of 20.6%

Prudent risk management with Q323 YTD loan loss rate (LLR) of 43bps

Strong balance sheet with CET1 ratio of 14.0%

c.7.5p total distributions per share announced at H123: dividend of 2.7p now paid, and completed the share buyback of £750m

 

Key financial metrics:

 


Income

Profit before tax

Attributable profit

Cost income ratio

LLR

RoTE

EPS

TNAV per share

CET1 ratio

Q323

£6.3bn

£1.9bn

£1.3bn

63%

42bps

11.0%

8.3p

316p

14.0%

Q323 YTD

£19.8bn

£6.4bn

£4.4bn

61%

43bps

12.5%

28.2p

 

Q323 Performance highlights:

 

Group RoTE of 11.0% with profit before tax of £1.9bn (Q322: £2.0bn). Excluding the impacts from the Over-issuance of Securities1,2 in the prior year:

 

-

Group income down 2% year-on-year to £6.3bn:



-

Barclays UK income decreased 2% to £1.9bn, primarily driven by the impact from the transfer of Wealth Management & Investments (WM&I) to Consumer, Cards and Payments (CC&P). Excluding the transfer, Barclays UK income was up 1%3 driven by net interest income growth from higher rates, including continued structural hedge income, partially offset by product dynamics in deposits and mortgages



-

Corporate and Investment Bank (CIB) income decreased 6% to £3.1bn, reflecting lower client activity in both Global Markets (against a record FICC performance in Q3224) and Investment Banking fees, more than offsetting higher Corporate income from higher rates and the non-repeat of fair value losses on leverage finance lending in the prior year



-

CC&P income increased 9% to £1.4bn reflecting higher balances in US cards and the benefit of the transfer of WM&I from Barclays UK


-

Group total operating expenses decreased 4% year-on-year to £3.9bn as inflation, business growth and investments were more than offset by efficiency savings and lower litigation and conduct charges

Credit impairment charges were £0.4bn, with an LLR of 42bps

CET1 ratio of 14.0%, with risk weighted assets (RWAs) of £341.9bn and tangible net asset value (TNAV) per share of 316p

 

1

Denotes the Over-issuance of Securities under Barclays Bank PLC's US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019. See page 5 for a reconciliation of financial results excluding the impact of the Over-issuance of Securities in the prior year.

2

Q322 impacts from the Over-Issuance of Securities: £0.5bn income reduction and £0.5bn reduction in litigation and conduct charges.

3

The income impact of the WM&I transfer was c.£60m in Q323.

4

Q322 was a record third quarter performance for FICC within Global Markets. Period covering Q114-Q323. Pre 2014 data was not restated following re-segmentation in Q116.

 

Q323 YTD Performance highlights:

 

Group RoTE was 12.5% (Q322 YTD: 10.9%) with profit before tax of £6.4bn (Q322 YTD: £5.7bn).

Excluding the impact of the Over-issuance of Securities in the prior year1:

 

-

Group income of £19.8bn, up 5% year-on-year


-

Group total operating expenses were £12.0bn, up 2% year-on-year. Cost: income ratio of 61% as the Group delivered positive cost: income jaws of 3%

Credit impairment charges were £1.3bn with an LLR of 43bps, with delinquencies in US cards in line with pre-pandemic experience

On a statutory basis:


-

Group income was £19.8bn, up 3% year-on-year


-

Group total operating expenses were £12.0bn, a decrease of 6% year-on-year

 

Group Targets and Outlook:

 

Costs: targeting a cost: income ratio percentage in the low 60s in 2023, investing for growth whilst progressing towards the Group's medium-term target of below 60%. Separately, the Group is evaluating actions to reduce structural costs to help drive future returns, which may result in material additional charges in Q423

Returns: targeting a RoTE of greater than 10% in 2023, excluding any such structural costs actions

Impairment: expect an LLR of 50-60bps through the cycle

Barclays UK Net Interest Margin (NIM): now expected to be in the range of 3.05% - 3.10% in 2023. Guidance is sensitive to the level and mix of deposit balances and further changes in expectations for interest rates

Capital: expect to continue to operate within the CET1 ratio target range of 13-14%

Capital returns: capital distribution policy incorporates a progressive ordinary dividend, supplemented with share buybacks as appropriate

 

1

Q322 YTD impacts from the Over-Issuance of Securities: £0.3bn income gain and £1.0bn litigation and conduct charges.

 

Barclays Group results

 

Nine months ended


Three months ended

30.09.23

30.09.22



30.09.23

30.09.22



£m

£m

% Change


£m

£m

% Change

Barclays UK

5,795

5,289

10


1,873

1,916

(2)

Corporate and Investment Bank

10,220

10,792

(5)


3,082

2,821

9

Consumer, Cards and Payments

3,944

3,213

23


1,360

1,244

9

Barclays International

14,164

14,005

1


4,442

4,065

9

Head Office

(179)

(139)

(29)


(57)

(30)

(90)

Total income

19,780

19,155

3


6,258

5,951

5

Operating costs

(11,979)

(11,209)

(7)


(3,949)

(3,939)

Litigation and conduct

(32)

(1,518)

98


-

339


Total operating expenses

(12,011)

(12,727)

6


(3,949)

(3,600)

(10)

Other net income/(expenses)

7

(4)



9

(1)


Profit before impairment

7,776

6,424

21


2,318

2,350

(1)

Credit impairment charges

(1,329)

(722)

(84)


(433)

(381)

(14)

Profit before tax

6,447

5,702

13


1,885

1,969

(4)

Tax charge

(1,257)

(1,072)

(17)


(343)

(249)

(38)

Profit after tax

5,190

4,630

12


1,542

1,720

(10)

Non-controlling interests

(39)

(23)

(70)


(9)

(2)


Other equity instrument holders

(766)

(620)

(24)


(259)

(206)

(26)

Attributable profit

4,385

3,987

10


1,274

1,512

(16)









Performance measures








Return on average tangible shareholders' equity

12.5%

10.9%



11.0%

12.5%


Average tangible shareholders' equity (£bn)

47.0

48.8



46.5

48.6


Cost: income ratio

61%

66%



63%

60%


Loan loss rate (bps)

43

23



42

36


Basic earnings per share

28.2p

24.2p



8.3p

9.4p


Basic weighted average number of shares (m)

15,564

16,503

(6)


15,405

16,148

(5)

Period end number of shares (m)

15,239

15,888

(4)


15,239

15,888

(4)

 


As at 30.09.23

As at 31.12.22

As at 30.09.22

Balance sheet and capital management1

£bn

£bn

£bn

Loans and advances at amortised cost

405.4

398.8

413.7

Loans and advances at amortised cost impairment coverage ratio

1.4%

1.4%

1.4%

Total assets

1,591.7

1,513.7

1,726.9

Deposits at amortised cost

561.3

545.8

574.4

Tangible net asset value per share

316p

295p

286p

Common equity tier 1 ratio

14.0%

13.9%

13.8%

Common equity tier 1 capital

48.0

46.9

48.6

Risk weighted assets

341.9

336.5

350.8

UK leverage ratio

5.0%

5.3%

5.0%

UK leverage exposure

1,202.4

1,130.0

1,232.1





Funding and liquidity




Group liquidity pool (£bn)

335.0

318.0

325.8

Liquidity coverage ratio2

159%

156%

156%

Net stable funding ratio3

138%

137%


Loan: deposit ratio

72%

73%

72%

 

1

Refer to pages 32 to 36 for further information on how capital, RWAs and leverage are calculated.

2

The Liquidity Coverage Ratio is now shown on an average basis, based on the average of the last 12 spot month end ratios. Prior period LCR comparatives have been updated for consistency.

3

Represents average of the last four spot quarter end positions.

 

Reconciliation of financial results excluding the impact of the Over-issuance of Securities in the prior year

 





Three months ended

30.09.23


30.09.22




Statutory


Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities




£m


£m

£m

£m


% Change

Barclays UK

1,873


1,916

-

1,916


(2)

Corporate and Investment Bank

3,082


2,821

(466)

3,287


(6)

Consumer, Cards and Payments

1,360


1,244

-

1,244


9

Barclays International

4,442


4,065

(466)

4,531


(2)

Head Office

(57)


(30)

-

(30)


(90)

Total income

6,258


5,951

(466)

6,417


(2)

Operating costs

(3,949)


(3,939)

-

(3,939)


Litigation and conduct

-


339

503

(164)



Total operating expenses

(3,949)


(3,600)

503

(4,103)


4

Other net income/(expenses)

9


(1)

-

(1)



Profit before impairment

2,318


2,350

37

2,313


Credit impairment charges

(433)


(381)

-

(381)


(14)

Profit before tax

1,885


1,969

37

1,932


(2)

Attributable profit

1,274


1,512

29

1,483


(14)









Average tangible shareholders' equity (£bn)

46.5


48.6


48.6



Return on average tangible shareholders' equity

11.0%


12.5%


12.2%











Nine months ended

30.09.23


30.09.22




Statutory


Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities




£m


£m

£m

£m


% Change

Barclays UK

5,795


5,289

-

5,289


10

Corporate and Investment Bank

10,220


10,792

292

10,500


(3)

Consumer, Cards and Payments

3,944


3,213

-

3,213


23

Barclays International

14,164


14,005

292

13,713


3

Head Office

(179)


(139)

-

(139)


(29)

Total income

19,780


19,155

292

18,863


5

Operating costs

(11,979)


(11,209)

-

(11,209)


(7)

Litigation and conduct

(32)


(1,518)

(966)

(552)


94

Total operating expenses

(12,011)


(12,727)

(966)

(11,761)


(2)

Other net income/(expenses)

7


(4)

-

(4)



Profit before impairment

7,776


6,424

(674)

7,098


10

Credit impairment charges

(1,329)


(722)

-

(722)


(84)

Profit before tax

6,447


5,702

(674)

6,376


1

Attributable profit

4,385


3,987

(552)

4,539


(3)









Average tangible shareholders' equity (£bn)

47.0


48.8


48.8



Return on average tangible shareholders' equity

12.5%


10.9%


12.4%



 

Group Finance Director's Review

 

Q323 YTD Group performance

 

Barclays delivered a profit before tax of £6,447m (Q322 YTD: £5,702m), RoTE of 12.5% (Q322 YTD: 10.9%) and earnings per share (EPS) of 28.2p (Q322 YTD: 24.2p)

The Group has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total operating expenses

Group income increased 3% to £19,780m primarily driven by the net benefit from the higher interest rate environment, including continued structural hedge income, and higher balances in US cards, partially offset by the non repeat of the prior year income from hedging arrangements related to the Over-issuance of Securities and lower income in Global Markets and Investment Banking fees

Group total operating expenses decreased to £12,011m (Q322 YTD: £12,727m)


-

Group operating expenses excluding litigation and conduct charges increased to £11,979m (Q322 YTD: £11,209m) reflecting the impact of business growth, including the Gap portfolio acquisition in US cards and the Kensington Mortgage Company (KMC) acquisition in Barclays UK, as well as investments in resilience and controls. The impact of Group inflation was broadly offset by efficiency savings. The Group incurred £119m of structural cost actions (Q322 YTD: £78m), primarily related to the ongoing Barclays UK transformation programme


-

Litigation and conduct charges decreased to £32m (Q322 YTD: £1,518m). The prior year charges included £966m of costs related to the Over-issuance of Securities, £282m of customer remediation costs relating to legacy loan portfolios in CC&P and £165m related to the Devices Settlements1

Credit impairment charges were £1,329m (Q322 YTD: £722m), with delinquencies in US cards in line with pre-pandemic experience. Total coverage ratio remains strong at 1.4% (December 2022: 1.4%)

The effective tax rate (ETR) was 19.5% (Q322 YTD: 18.8%). The prior year included tax benefits arising in the year and in respect of prior years, which were partially offset by the impact of the downward re-measurement of the Group's UK deferred tax assets as a result of the UK banking surcharge rate being reduced from 8% to 3%

Attributable profit was £4,385m (Q322 YTD: £3,987m)

Total assets increased to £1,591.7bn (December 2022: £1,513.7bn) driven by increased trading activity within CIB since December 2022. The Group liquidity pool was further strengthened by deposit growth

TNAV per share increased to 316p (December 2022: 295p) as EPS of 28.2p and the impact of share buybacks announced at FY22 and H123 results were partially offset by dividends paid in the period and net negative reserve movements

 

Barclays UK

 

Barclays UK delivered a RoTE of 20.6% supported by the higher interest rate environment and the continued investment in our transformation into a next-generation, digitised consumer bank. The challenging environment has persisted with customer behaviour driving a reduction in the NIM outlook and balances.

 

Profit before tax increased 16% to £2,300m with a RoTE of 20.6% (Q322 YTD: 18.7%)

Total income increased 10% to £5,795m. Net interest income increased 13% to £4,856m with a NIM of 3.15% (Q322 YTD: 2.78%), as higher interest rates and associated structural hedge benefit outweighed mortgage margin pressure, lower deposit volumes and the search for yield in savings, with these product dynamics trends increasing in Q323. Net fee, commission and other income decreased 6% to £939m including the impact of the transfer of WM&I to CC&P


-

Personal Banking income increased 11% to £3,662m, driven by higher interest rates, partially offset by mortgage margin compression and lower current accounts deposit volumes consistent with wider market trends and cost of living pressures


-

Barclaycard Consumer UK income decreased 12% to £722m as higher customer spend volumes were more than offset by lower interest earning lending balances following repayments and ongoing prudent risk management


-

Business Banking income increased 22% to £1,411m driven by higher interest rates, partially offset by lower government scheme lending as repayments continue and lower deposit volumes in line with wider market trends

Total operating expenses increased 2% to £3,228m from the impact of inflation, partially offset by the transfer of WM&I to CC&P. Ongoing efficiency savings continue to be reinvested, including in our transformation programme to support further improvements to the cost: income ratio over time

Credit impairment charges increased to £267m (Q322 YTD: £129m), driven by updated macroeconomic scenarios, reflecting year-to-date improvement in GDP and unemployment outlook against a backdrop of higher interest rates and a weaker House Price Index (HPI). UK cards 30 and 90 day arrears remained low at 0.9% (Q322: 1.0%) and 0.2% (Q322: 0.3%) respectively. The UK cards total coverage ratio was 6.3% (December 2022: 7.6%)

 

1

Refers to the settlements with the SEC and Commodity Futures Trading Commission (CFTC) in connection with their investigations of the use of unauthorised devices for business communications.

 

Barclays UK (continued)

 

Loans and advances to customers at amortised cost were broadly stable at £204.9bn (December 2022: £205.1bn), primarily reflecting the acquisition of KMC and mortgage lending in the first half of the year, which more than offset repayment of government scheme lending in Business Banking

Customer deposits at amortised cost decreased 6% to £243.2bn. Primarily driven by reduced current account balances in Personal and Business Banking, reflecting broader market trends. The loan: deposit ratio increased to 92% (December 2022: 87%)


-

Average balances quarter-on-quarter contributed to a larger net interest income deposit effect than the period end balances

RWAs were stable at £73.2bn (December 2022: £73.1bn) including a reduction due to a capital Loss Given Default (LGD) model update for the mortgages portfolio, partially offset by the acquisition of KMC

 

Barclays International

 

Barclays International delivered a RoTE of 11.4%. Despite the reduced banking industry fee pool and lower client activity in Global Markets, CIB delivered a RoTE of 11.5% reflecting the benefits of income diversification and investment in sustainable growth. CC&P delivered a RoTE of 10.6% reflecting continued investment in the business resulting in balance growth and increased income, partially offset by higher impairment charges.

 

Profit before tax increased 10% to £4,580m with a RoTE of 11.4% (Q322 YTD: 11.5%), reflecting a RoTE of 11.5% (Q322 YTD: 11.9%) in CIB and 10.6% (Q322 YTD: 8.9%) in CC&P

Barclays International has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits, and adversely impacted credit impairment charges and total operating expenses

Total income increased to £14,164m (Q322 YTD: £14,005m)


-

CIB income decreased 5% to £10,220m and 3% excluding the impact from prior year hedging arrangements related to the Over-issuance of Securities1



-

Global Markets income decreased 18% to £6,063m. FICC income decreased 13% to £4,121m, driven by macro reflecting lower market volatility and client activity, partially offset by strong performance in credit. Equities income decreased 28% to £1,942m, driven by a decline in derivatives income reflecting less volatile equity market conditions. Excluding the impact from the Over-issuance of Securities, Equities income decreased by 20%



-

Investment Banking fees decreased 16% to £1,450m due to the reduced fee pool across Advisory and Debt capital markets2, partially offset by an improvement in Equity capital markets



-

Within Corporate, Transaction banking income increased 31% to £2,272m driven by improved deposit margins in the higher interest rate environment. Corporate lending income increased to £435m (Q322 YTD: £103m loss) mainly driven by lower costs of hedging and the non-repeat of fair value losses on leverage finance lending net of mark to market gains on related hedges in the prior year


-

CC&P income increased 23% to £3,944m



-

International Cards and Consumer Bank income increased 28% to £2,625m reflecting higher cards balances and improved margins, including the Gap portfolio acquisition in Q222



-

Private Bank income increased 21% to £884m, due to the transfer of WM&I from Barclays UK, client balance growth and improved margins



-

Payments income was stable at £435m (Q322 YTD: £431m) driven by merchant acquiring growth, partially offset by margin compression

Total operating expenses decreased 8% to £8,559m, and excluding litigation and conduct increased 9% to £8,519m, reflecting investment in the business


-

CIB total operating expenses decreased 11% to £6,192m. Operating expenses excluding litigation and conduct charges increased 6% to £6,201m reflecting investment in talent and technology, and the impact of inflation, partially offset by efficiency savings


-

CC&P total operating expenses increased 4% to £2,367m. Operating expenses excluding litigation and conduct charges increased 17% to £2,318m, driven by higher investment spend to support growth, mainly in marketing and partnership costs including the Gap portfolio acquisition, the transfer of WM&I from Barclays UK and the impact of inflation, partially offset by efficiency savings

 

1

Q322 YTD included £292m of income gain related to hedging arrangements to manage the risks of the rescission offer in relation to the Over-issuance of Securities.

2

Data source: Dealogic for the period covering 1 January to 30 September 2023.

 

Barclays International (continued)

 

Credit impairment charges were £1,037m (Q322 YTD: £605m)


-

CIB credit impairment charges were £nil (Q322 YTD: £78m) driven by single name charges offset by the benefit of credit protection and the updated macroeconomic scenarios


-

CC&P credit impairment charges increased to £1,037m (Q322 YTD: £527m), with delinquencies in US cards in line with pre-pandemic experience, with 30 and 90 day arrears at 2.7% (Q322: 2.0%) and 1.3% (Q322: 0.8%) respectively. The US cards total coverage ratio was 9.7% (December 2022: 8.1%)

RWAs increased to £259.2bn (December 2022: £254.8bn) due to increased trading activity within CIB since Q422, partially offset by the impact of strengthening of GBP against USD


-

RWAs were broadly stable since June 2023, excluding the impact of spot USD appreciation against GBP

 

Head Office

 

Loss before tax was £433m (Q322 YTD: £446m)

Total income was an expense of £179m (Q322 YTD: £139m) primarily reflecting hedge accounting and treasury items. The prior year included a one-off gain of £86m from the sale and leaseback of UK data centres, as well as a £74m loss on sale arising from disposals of Barclays' equity stake in Absa Group Limited

Total operating expenses decreased to £224m (Q322 YTD: £293m) primarily driven by lower litigation and conduct charges

RWAs were £9.5bn (December 2022: £8.6bn)

 

Capital distributions

 

Barclays paid a half-year dividend of 2.7p per share on 15 September 2023, and completed the share buyback of £750m announced at H123 results, bringing the total capital return equivalent to c.7.5p per share

Barclays is committed to maintaining a balance between a strong capital position, delivering total cash returns to shareholders and investment in the business. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividend as appropriate, including with share buybacks

 

Group capital and leverage

 

The CET1 ratio increased to 14.0% (December 2022: 13.9%) as CET1 capital increased by £1.1bn to £48.0bn (December 2022: £46.9bn) partially offset by an increase in RWAs of £5.4bn to £341.9bn (December 2022: £336.5bn):


-

c.130bps increase from attributable profit generated in the period


-

c.60bps decrease driven by returns to shareholders including the interim dividend of 2.7p per share paid in September 2023 and £1.3bn of share buybacks announced with FY22 and H123 results. It also includes an accrual towards the FY23 dividend


-

c.30bps decrease from other capital movements, including the impact of regulatory change on 1 January 2023 relating to IFRS 9 transitional relief, the impact of the KMC acquisition, and other regulatory capital deductions


-

c.30bps decrease as a result of a £7.4bn increase in RWAs primarily driven by increased trading activity within CIB since December 2022


-

A £3.2bn decrease in RWAs as a result of foreign exchange movements since December 2022 was broadly offset by a £0.4bn decrease in CET1 capital due to a decrease in the currency translation reserve

The UK leverage ratio decreased to 5.0% (December 2022: 5.3%) primarily due to a £72.4bn increase in leverage exposure to £1,202.4bn (December 2022: £1,130.0bn). This is largely driven by increased trading activity within CIB since December 2022

 

Group funding and liquidity

 

The liquidity and funding position remains robust and stable in the period. The liquidity pool increased to £335.0bn (December 2022: £318.0bn) driven by deposit growth. The composition of the liquidity pool is conservative, with 81% held in cash and deposits with central banks and the remainder primarily held in high quality government bonds, materially held at fair value or hedged

The strength of the funding and liquidity position is supported by a diverse and stable deposit franchise. Total deposits increased to £561.3bn (December 2022: £545.8bn)

The average1 Liquidity Coverage Ratio (LCR) remained significantly above the 100% regulatory requirement at 159% (December 2022: 156%), equivalent to a surplus of £115.6bn (December 2022: £114.4bn)

The average2 Net Stable Funding Ratio was 138% (December 2022: 137%), which represents a £165.8bn (December 2022: £155.6bn) surplus above the 100% regulatory requirement

Wholesale funding outstanding, excluding repurchase agreements, was £186.4bn (December 2022: £184.0bn)

The Group issued £12.0bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) year to date. The Group has a strong MREL position with a ratio of 33.4%, which is in excess of the regulatory requirement of 29.6% plus a confidential, institution specific, Prudential Regulation Authority (PRA) buffer

 

Other matters

 

KMC acquisition: on 1 March 2023, Barclays completed the acquisition of UK specialist mortgage lender KMC, including a portfolio of mortgages totalling £2.2bn with an RWA impact of £0.8bn

Combination of the Private Bank and Barclays UK Wealth business: on 1 May 2023, WM&I was transferred from Barclays UK to CC&P, creating a combined Private Bank and Wealth Management business. The combination seeks to improve customer and client experience and create business synergies:


-

The business transferred includes c.£28bn of invested assets, generating annualised income of c.£0.2bn

 

1

Represents average of the last 12 spot month end ratios.

2

Represents average of the last four spot quarter end ratios.

 

Anna Cross, Group Finance Director

 

Results by Business

 

Barclays UK

Nine months ended


Three months ended


30.09.23

30.09.22



30.09.23

30.09.22


Income statement information

£m

£m

% Change


£m

£m

% Change

Net interest income

4,856

4,293

13


1,578

1,561

1

Net fee, commission and other income

939

996

(6)


295

355

(17)

Total income

5,795

5,289

10


1,873

1,916

(2)

Operating costs

(3,240)

(3,152)

(3)


(1,058)

(1,069)

1

Litigation and conduct

12

(28)



9

(3)


Total operating expenses

(3,228)

(3,180)

(2)


(1,049)

(1,072)

2

Other net expenses

-

(1)



-

(1)


Profit before impairment

2,567

2,108

22


824

843

(2)

Credit impairment charges

(267)

(129)



(59)

(81)

27

Profit before tax

2,300

1,979

16


765

762

Attributable profit

1,580

1,403

13


531

549

(3)









Performance measures








Return on average allocated tangible equity

20.6%

18.7%



21.0%

22.1%


Average allocated tangible equity (£bn)

10.2

10.0



10.1

9.9


Cost: income ratio

56%

60%



56%

56%


Loan loss rate (bps)

16

8



10

14


Net interest margin

3.15%

2.78%



3.04%

3.01%











As at 30.09.23

As at 31.12.22

As at 30.09.22





Balance sheet information

£bn

£bn

£bn





Loans and advances to customers at amortised cost

204.9

205.1

205.1





Total assets

299.9

313.2

316.8





Customer deposits at amortised cost

243.2

258.0

261.0





Loan: deposit ratio

92%

87%

86%





Risk weighted assets

73.2

73.1

73.2





Period end allocated tangible equity

10.1

10.1

10.1





 

Analysis of Barclays UK

Nine months ended


Three months ended

30.09.23

30.09.22



30.09.23

30.09.22


Analysis of total income

£m

£m

% Change


£m

£m

% Change

Personal Banking

3,662

3,311

11


1,165

1,212

(4)

Barclaycard Consumer UK

722

824

(12)


238

283

(16)

Business Banking

1,411

1,154

22


470

421

12

Total income

5,795

5,289

10


1,873

1,916

(2)









Analysis of credit impairment (charges)/releases








Personal Banking

(205)

(47)



(85)

(26)


Barclaycard Consumer UK

(89)

42



29

2


Business Banking

27

(124)



(3)

(57)

95

Total credit impairment charges

(267)

(129)

 


(59)

(81)

27










As at 30.09.23

As at 31.12.22

As at 30.09.22





Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn





Personal Banking

172.3

169.7

168.7





Barclaycard Consumer UK

9.6

9.2

9.0





Business Banking

23.0

26.2

27.4





Total loans and advances to customers at amortised cost

204.9

205.1

205.1













Analysis of customer deposits at amortised cost








Personal Banking

186.1

195.6

197.3





Barclaycard Consumer UK

-

-

-





Business Banking

57.1

62.4

63.7





Total customer deposits at amortised cost

243.2

258.0

261.0





 

Barclays International

Nine months ended


Three months ended


30.09.23

30.09.22



30.09.23

30.09.22


Income statement information

£m

£m

% Change


£m

£m

% Change

Net interest income

4,739

3,462

37


1,655

1,497

11

Net trading income

5,158

6,540

(21)


1,461

1,328

10

Net fee, commission and other income

4,267

4,003

7


1,326

1,240

7

Total income

14,164

14,005

1


4,442

4,065

9

Operating costs

(8,519)

(7,818)

(9)


(2,816)

(2,776)

(1)

Litigation and conduct

(40)

(1,436)

97


(10)

396


Total operating expenses

(8,559)

(9,254)

8


(2,826)

(2,380)

(19)

Other net income

12

23

(48)


3

10

(70)

Profit before impairment

5,617

4,774

18


1,619

1,695

(4)

Credit impairment charges

(1,037)

(605)

(71)


(358)

(295)

(21)

Profit before tax

4,580

4,169

10


1,261

1,400

(10)

Attributable profit

3,149

3,219

(2)


848

1,136

(25)









Performance measures








Return on average allocated tangible equity

11.4%

11.5%



9.2%

11.6%


Average allocated tangible equity (£bn)

37.0

37.2



36.8

39.1


Cost: income ratio

60%

66%



64%

59%


Loan loss rate (bps)

77

43



78

62


Net interest margin

5.90%

       4.78%



5.98%

       5.58%











As at 30.09.23

As at 31.12.22

As at 30.09.22





Balance sheet information

£bn

£bn

£bn





Loans and advances to customers at amortised cost

130.8

133.7

137.0





Loans and advances to banks at amortised cost

10.3

8.7

11.0





Debt securities at amortised cost

36.4

27.2

36.2





Loans and advances at amortised cost

177.5

169.6

184.2





Trading portfolio assets

155.4

133.8

126.3





Derivative financial instrument assets

280.4

301.7

415.7





Financial assets at fair value through the income statement

238.3

210.5

244.7





Cash collateral and settlement balances

136.0

107.7

163.3





Other assets

285.5

258.0

257.2





Total assets

1,273.1

1,181.3

1,391.4





Deposits at amortised cost

318.2

287.6

313.2





Derivative financial instrument liabilities

268.3

288.9

394.2





Loan: deposit ratio

56%

59%

59%





Risk weighted assets

259.2

254.8

269.3





Period end allocated tangible equity

37.1

36.8

38.8





 

Analysis of Barclays International







Corporate and Investment Bank

Nine months ended


Three months ended


30.09.23

30.09.22



30.09.23

30.09.22


Income statement information

£m

£m

% Change


£m

£m

% Change

Net interest income

2,021

1,401

44


700

606

16

Net trading income

5,294

6,532

(19)


1,503

1,344

12

Net fee, commission and other income

2,905

2,859

2


879

871

1

Total income

10,220

10,792

(5)


3,082

2,821

9

Operating costs

(6,201)

(5,834)

(6)


(2,015)

(2,043)

1

Litigation and conduct

9

(1,134)



7

498

(99)

Total operating expenses

(6,192)

(6,968)

11


(2,008)

(1,545)

(30)

Other net income

3

-



2

-


Profit before impairment

4,031

3,824

5


1,076

1,276

(16)

Credit impairment (charges)/releases

-

(78)



20

(46)


Profit before tax

4,031

3,746

8


1,096

1,230

(11)

Attributable profit

2,728

2,910

(6)


721

1,015

(29)









Performance measures








Return on average allocated tangible equity

11.5%

11.9%



9.2%

11.9%


Average allocated tangible equity (£bn)

31.7

32.5



31.5

34.0


Cost: income ratio

61%

65%



65%

55%


Loan loss rate (bps)

-

7



(6)

13











As at 30.09.23

As at 31.12.22

As at 30.09.22





Balance sheet information

£bn

£bn

£bn





Loans and advances to customers at amortised cost

87.9

90.5

93.6





Loans and advances to banks at amortised cost

9.6

8.1

10.2





Debt securities at amortised cost

36.3

27.2

36.2





Loans and advances at amortised cost

133.8

125.8

140.0





Trading portfolio assets

155.3

133.7

126.1





Derivative financial instrument assets

280.4

301.6

415.5





Financial assets at fair value through the income statement

238.2

210.5

244.6





Cash collateral and settlement balances

135.2

106.9

162.6





Other assets

237.2

222.6

220.6





Total assets

1,180.1

1,101.1

1,309.4





Deposits at amortised cost

236.9

205.8

229.5





Derivative financial instrument liabilities

268.3

288.9

394.2





Risk weighted assets

219.2

215.9

230.6














Nine months ended


Three months ended


30.09.23

30.09.22



30.09.23

30.09.22


Analysis of total income

£m

£m

% Change


£m

£m

% Change

FICC

4,121

4,719

(13)


1,147

1,546

(26)

Equities

1,942

2,709

(28)


675

246


Global Markets

6,063

7,428

(18)


1,822

1,792

2

Advisory

422

571

(26)


80

150

(47)

Equity capital markets

181

126

44


62

42

48

Debt capital markets

847

1,038

(18)


233

341

(32)

Investment Banking fees

1,450

1,735

(16)


375

533

(30)

Corporate lending

435

(103)



172

(181)


Transaction banking

2,272

1,732

31


713

677

5

Corporate

2,707

1,629

66


885

496

78

Total income

10,220

10,792

(5)


3,082

2,821

9

 

Analysis of Barclays International







Consumer, Cards and Payments

Nine months ended


Three months ended


30.09.23

30.09.22



30.09.23

30.09.22


Income statement information

£m

£m

% Change


£m

£m

% Change

Net interest income

2,718

2,061

32


955

891

7

Net fee, commission, trading and other income

1,226

1,152

6


405

353

15

Total income

3,944

3,213

23


1,360

1,244

9

Operating costs

(2,318)

(1,984)

(17)


(801)

(733)

(9)

Litigation and conduct

(49)

(302)

84


(17)

(102)

83

Total operating expenses

(2,367)

(2,286)

(4)


(818)

(835)

2

Other net income

9

23

(61)


1

10

(90)

Profit before impairment

1,586

950

67


543

419

30

Credit impairment charges

(1,037)

(527)

(97)


(378)

(249)

(52)

Profit before tax

549

423

30


165

170

(3)

Attributable profit

421

309

36


127

121

5









Performance measures








Return on average allocated tangible equity

10.6%

8.9%



9.6%

9.5%


Average allocated tangible equity (£bn)

5.3

4.7



5.3

5.1


Cost: income ratio

60%

71%



60%

67%


Loan loss rate (bps)

297

150



321

211











As at 30.09.23

As at 31.12.22

As at 30.09.22





Balance sheet information

£bn

£bn

£bn





Loans and advances to customers at amortised cost

42.9

43.2

43.4





Total assets

93.0

80.2

82.0





Deposits at amortised cost

81.3

81.8

83.7





Risk weighted assets

39.9

38.9

38.7














Nine months ended


Three months ended


30.09.23

30.09.22



30.09.23

30.09.22


Analysis of total income

£m

£m

% Change


£m

£m

% Change

International Cards and Consumer Bank

2,625

2,053

28


890

824

8

Private Bank

884

729

21


331

270

23

Payments

435

431

1


139

150

(7)

Total income

3,944

3,213

23


1,360

1,244

9

 

Head Office

Nine months ended


Three months ended


30.09.23

30.09.22



30.09.23

30.09.22


Income statement information

£m

£m

% Change


£m

£m

% Change

Net interest income

(25)

76



14

10

40

Net fee, commission and other income

(154)

(215)

28


(71)

(40)

(78)

Total income

(179)

(139)

(29)


(57)

(30)

(90)

Operating costs

(220)

(239)

8


(75)

(94)

20

Litigation and conduct

(4)

(54)

93


1

(54)


Total operating expenses

(224)

(293)

24


(74)

(148)

50

Other net (expenses)/income

(5)

(26)

81


6

(10)


Loss before impairment

(408)

(458)

11


(125)

(188)

34

Credit impairment (charges)/releases

(25)

12



(16)

(5)


Loss before tax

(433)

(446)

3


(141)

(193)

27

Attributable loss

(344)

(635)

46


(105)

(173)

39









Performance measures








Average allocated tangible equity (£bn)

(0.2)

1.6



(0.4)

(0.4)











As at 30.09.23

As at 31.12.22

As at 30.09.22





Balance sheet information

£bn

£bn

£bn





Total assets

18.7

19.2

18.7





Risk weighted assets

9.5

8.6

8.2





Period end allocated tangible equity

1.0

(0.2)

(3.5)





 

Quarterly Results Summary

 

Barclays Group












Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q4211

Income statement information

£m

£m

£m


£m

£m

£m

£m


£m

Net interest income

3,247

3,270

3,053


2,741

3,068

2,422

2,341


2,230

Net fee, commission and other income

3,011

3,015

4,184


3,060

2,883

4,286

4,155


2,930

Total income

6,258

6,285

7,237


5,801

5,951

6,708

6,496


5,160

Operating costs

(3,949)

(3,919)

(4,111)


(3,748)

(3,939)

(3,682)

(3,588)


(3,514)

UK bank levy

-

-

-


(176)

-

-

-


(170)

Litigation and conduct

-

(33)

1


(79)

339

(1,334)

(523)


(92)

Total operating expenses

(3,949)

(3,952)

(4,110)


(4,003)

(3,600)

(5,016)

(4,111)


(3,776)

Other net income/(expenses)

9

3

(5)


10

(1)

7

(10)


13

Profit before impairment

2,318

2,336

3,122


1,808

2,350

1,699

2,375


1,397

Credit impairment (charges)/releases

(433)

(372)

(524)


(498)

(381)

(200)

(141)


31

Profit before tax

1,885

1,964

2,598


1,310

1,969

1,499

2,234


1,428

Tax (charge)/credit

(343)

(353)

(561)


33

(249)

(209)

(614)


(104)

Profit after tax

1,542

1,611

2,037


1,343

1,720

1,290

1,620


1,324

Non-controlling interests

(9)

(22)

(8)


(22)

(2)

(20)

(1)


(27)

Other equity instrument holders

(259)

(261)

(246)


(285)

(206)

(199)

(215)


(218)

Attributable profit

1,274

1,328

1,783


1,036

1,512

1,071

1,404


1,079












Performance measures











Return on average tangible shareholders' equity

11.0%

11.4%

15.0%


8.9%

12.5%

8.7%

11.5%


9.0%

Average tangible shareholders' equity (£bn)

46.5

46.7

47.6


46.7

48.6

49.0

48.8


48.0

Cost: income ratio

63%

63%

57%


69%

60%

75%

63%


73%

Loan loss rate (bps)

42

37

52


49

36

20

15


(3)

Basic earnings per share

8.3p

8.6p

11.3p


6.5p

9.4p

6.4p

8.4p


6.4p

Basic weighted average number of shares (m)

15,405

15,523

15,770


15,828

16,148

16,684

16,682


16,985

Period end number of shares (m)

15,239

15,556

15,701


15,871

15,888

16,531

16,762


16,752












Balance sheet and capital management2

£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Loans and advances to customers at amortised cost

339.6

337.4

343.6


343.3

346.3

337.2

325.8


319.9

Loans and advances to banks at amortised cost

11.5

10.9

11.0


10.0

12.5

12.5

11.4


9.7

Debt securities at amortised cost

54.3

53.1

48.9


45.5

54.8

46.1

34.5


31.8

Loans and advances at amortised cost

405.4

401.4

403.5


398.8

413.7

395.8

371.7


361.5

Loans and advances at amortised cost impairment coverage ratio

1.4%

1.4%

1.4%


1.4%

1.4%

1.4%

1.5%


1.6%

Total assets

1,591.7

1,549.7

1,539.1


1,513.7

1,726.9

1,589.2

1,496.1


1,384.3

Deposits at amortised cost

561.3

554.7

555.7


545.8

574.4

568.7

546.5


519.4

Tangible net asset value per share

316p

291p

301p


295p

286p

297p

294p


291p

Common equity tier 1 ratio

14.0%

13.8%

13.6%


13.9%

13.8%

13.6%

13.8%


15.1%

Common equity tier 1 capital

48.0

46.6

46.0


46.9

48.6

46.7

45.3


47.3

Risk weighted assets

341.9

336.9

338.4


336.5

350.8

344.5

328.8


314.1

UK leverage ratio

5.0%

5.1%

5.1%


5.3%

5.0%

5.1%

5.0%


5.2%

UK leverage exposure

1,202.4

1,183.7

1,168.9


1,130.0

1,232.1

1,151.2

1,123.5


1,137.9












Funding and liquidity











Group liquidity pool (£bn)

335.0

330.7

333.0


318.0

325.8

342.5

319.8


291.0

Liquidity coverage ratio3

159%

157%

157%


156%

156%

157%

159%


160%

Net stable funding ratio4

138%

139%

139%


137%






Loan: deposit ratio

72%

72%

73%


73%

72%

70%

68%


70%

 

1

The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

2

Refer to pages 32 to 36 for further information on how capital, RWAs and leverage are calculated.

3

The Liquidity Coverage Ratio is based on the average of the last 12 spot month end ratios. Prior period LCR comparatives have been updated for consistency.

4

Represents average of the last four spot quarter end positions.

 

Quarterly Results by Business

 

Barclays UK












Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q421

Income statement information

£m

£m

£m


£m

£m

£m

£m


£m

Net interest income

1,578

1,660

1,618


1,600

1,561

1,393

1,339


1,313

Net fee, commission and other income

295

301

343


370

355

331

310


386

Total income

1,873

1,961

1,961


1,970

1,916

1,724

1,649


1,699

Operating costs

(1,058)

(1,090)

(1,092)


(1,108)

(1,069)

(1,085)

(998)


(1,202)

UK bank levy

-

-

-


(26)

-

-

-


(36)

Litigation and conduct

9

5

(2)


(13)

(3)

(16)

(9)


(5)

Total operating expenses

(1,049)

(1,085)

(1,094)


(1,147)

(1,072)

(1,101)

(1,007)


(1,243)

Other net income/(expenses)

-

-

-


1

(1)

-

-


(1)

Profit before impairment

824

876

867


824

843

623

642


455

Credit impairment (charges)/releases

(59)

(95)

(113)


(157)

(81)

-

(48)


59

Profit before tax

765

781

754


667

762

623

594


514

Attributable profit

531

534

515


474

549

458

396


420












Balance sheet information

£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Loans and advances to customers at amortised cost

204.9

206.8

208.2


205.1

205.1

205.9

207.3


208.8

Total assets

299.9

304.8

308.6


313.2

316.8

318.8

317.2


321.2

Customer deposits at amortised cost

243.2

249.8

254.3


258.0

261.0

261.5

260.3


260.6

Loan: deposit ratio

92%

90%

90%


87%

86%

85%

85%


85%

Risk weighted assets

73.2

73.0

74.6


73.1

73.2

72.2

72.7


72.3

Period end allocated tangible equity

10.1

10.1

10.3


10.1

10.1

9.9

10.1


10.0












Performance measures











Return on average allocated tangible equity

21.0%

20.9%

20.0%


18.7%

22.1%

18.4%

15.6%


16.8%

Average allocated tangible equity (£bn)

10.1

10.2

10.3


10.2

9.9

10.0

10.1


10.0

Cost: income ratio

56%

55%

56%


58%

56%

64%

61%


73%

Loan loss rate (bps)

10

17

20


27

14

-

9


(10)

Net interest margin

3.04%

3.22%

3.18%


3.10%

3.01%

2.71%

2.62%


2.49%

 

Analysis of Barclays UK

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q421

Analysis of total income

£m

£m

£m


£m

£m

£m

£m


£m

Personal Banking

1,165

1,244

1,253


1,229

1,212

1,077

1,022


983

Barclaycard Consumer UK

238

237

247


269

283

265

276


352

Business Banking

470

480

461


472

421

382

351


364

Total income

1,873

1,961

1,961


1,970

1,916

1,724

1,649


1,699












Analysis of credit impairment (charges)/releases











Personal Banking

(85)

(92)

(28)


(120)

(26)

(42)

21


8

Barclaycard Consumer UK

29

(35)

(83)


(12)

2

84

(44)


114

Business Banking

(3)

32

(2)


(25)

(57)

(42)

(25)


(63)

Total credit impairment (charges)/releases

(59)

(95)

(113)


(157)

(81)

-

(48)


59












Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Personal Banking

172.3

173.3

173.6


169.7

168.7

167.1

166.5


165.4

Barclaycard Consumer UK

9.6

9.3

9.0


9.2

9.0

8.8

8.4


8.7

Business Banking

23.0

24.2

25.6


26.2

27.4

30.0

32.4


34.7

Total loans and advances to customers at amortised cost

204.9

206.8

208.2


205.1

205.1

205.9

207.3


208.8












Analysis of customer deposits at amortised cost











Personal Banking

186.1

191.1

194.3


195.6

197.3

197.0

196.6


196.4

Barclaycard Consumer UK

-

-

-


-

-

-

-


-

Business Banking

57.1

58.7

60.0


62.4

63.7

64.5

63.7


64.2

Total customer deposits at amortised cost

243.2

249.8

254.3


258.0

261.0

261.5

260.3


260.6

 

Barclays International












Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q4211

Income statement information

£m

£m

£m


£m

£m

£m

£m


£m

Net interest income

1,655

1,730

1,354


1,465

1,497

1,029

936


955

Net trading income

1,461

1,278

2,419


1,169

1,328

2,766

2,446


789

Net fee, commission and other income

1,326

1,432

1,509


1,228

1,240

1,321

1,442


1,766

Total income

4,442

4,440

5,282


3,862

4,065

5,116

4,824


3,510

Operating costs

(2,816)

(2,747)

(2,956)


(2,543)

(2,776)

(2,537)

(2,505)


(2,160)

UK bank levy

-

-

-


(133)

-

-

-


(134)

Litigation and conduct

(10)

(33)

3


(67)

396

(1,319)

(513)


(84)

Total operating expenses

(2,826)

(2,780)

(2,953)


(2,743)

(2,380)

(3,856)

(3,018)


(2,378)

Other net income

3

6

3


5

10

5

8


3

Profit before impairment

1,619

1,666

2,332


1,124

1,695

1,265

1,814


1,135

Credit impairment charges

(358)

(275)

(404)


(328)

(295)

(209)

(101)


(23)

Profit before tax

1,261

1,391

1,928


796

1,400

1,056

1,713


1,112

Attributable profit

848

953

1,348


625

1,136

783

1,300


818












Balance sheet information

£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Loans and advances to customers at amortised cost

130.8

126.6

131.0


133.7

137.0

126.7

113.9


106.4

Loans and advances to banks at amortised cost

10.3

9.7

9.8


8.7

11.0

11.3

10.2


8.4

Debt securities at amortised cost

36.4

35.2

30.8


27.2

36.2

29.3

20.7


19.0

Loans and advances at amortised cost

177.5

171.5

171.6


169.6

184.2

167.3

144.8


133.8

Trading portfolio assets

155.4

165.1

137.7


133.8

126.3

126.9

134.1


146.9

Derivative financial instrument assets

280.4

264.9

256.6


301.7

415.7

343.5

288.8


261.5

Financial assets at fair value through the income statement

238.3

232.2

245.0


210.5

244.7

209.3

203.8


188.2

Cash collateral and settlement balances

136.0

123.9

125.5


107.7

163.3

128.5

132.0


88.1

Other assets

285.5

268.8

275.0


258.0

257.2

275.1

255.5


225.6

Total assets

1,273.1

1,226.4

1,211.4


1,181.3

1,391.4

1,250.6

1,159.0


1,044.1

Deposits at amortised cost

318.2

305.0

301.6


287.6

313.2

307.4

286.1


258.8

Derivative financial instrument liabilities

268.3

254.5

246.7


288.9

394.2

321.2

277.2


256.4

Loan: deposit ratio

56%

56%

57%


59%

59%

54%

51%


52%

Risk weighted assets

259.2

254.6

255.1


254.8

269.3

263.8

245.1


230.9

Period end allocated tangible equity

37.1

36.7

36.8


36.8

38.8

38.0

35.6


33.2












Performance measures











Return on average allocated tangible equity

9.2%

10.3%

14.5%


6.4%

11.6%

8.4%

14.8%


9.9%

Average allocated tangible equity (£bn)

36.8

37.1

37.1


38.9

39.1

37.3

35.1


32.9

Cost: income ratio

64%

63%

56%


71%

59%

75%

63%


68%

Loan loss rate (bps)

78

63

94


75

62

49

28


7

Net interest margin

5.98%

5.85%

5.87%


5.71%

5.58%

4.41%

4.15%


4.14%

 

1

The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Analysis of Barclays International






















Corporate and Investment Bank

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q4211

Income statement information

£m

£m

£m


£m

£m

£m

£m


£m

Net interest income

700

856

465


548

606

410

385


432

Net trading income

1,503

1,353

2,437


1,201

1,344

2,738

2,450


774

Net fee, commission and other income

879

953

1,074


827

871

885

1,103


1,426

Total income

3,082

3,162

3,976


2,576

2,821

4,033

3,938


2,632

Operating costs

(2,015)

(1,984)

(2,202)


(1,796)

(2,043)

(1,870)

(1,921)


(1,562)

UK bank levy

-

-

-


(126)

-

-

-


(128)

Litigation and conduct

7

(1)

3


(55)

498

(1,314)

(318)


(59)

Total operating expenses

(2,008)

(1,985)

(2,199)


(1,977)

(1,545)

(3,184)

(2,239)


(1,749)

Other net income

2

1

-


2

-

-

-


1

Profit before impairment

1,076

1,178

1,777


601

1,276

849

1,699


884

Credit impairment releases/(charges)

20

13

(33)


(41)

(46)

(65)

33


73

Profit before tax

1,096

1,191

1,744


560

1,230

784

1,732


957

Attributable profit

721

798

1,209


454

1,015

579

1,316


695












Balance sheet information

£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Loans and advances to customers at amortised cost

87.9

84.8

89.2


90.5

93.6

86.5

79.5


73.4

Loans and advances to banks at amortised cost

9.6

9.0

9.2


8.1

10.2

10.0

9.4


7.6

Debt securities at amortised cost

36.3

35.1

30.7


27.2

36.2

29.3

20.7


19.0

Loans and advances at amortised cost

133.8

128.9

129.1


125.8

140.0

125.8

109.6


100.0

Trading portfolio assets

155.3

165.0

137.6


133.7

126.1

126.7

134.0


146.7

Derivative financial instruments assets

280.4

264.8

256.5


301.6

415.5

343.4

288.7


261.5

Financial assets at fair value through the income statement

238.2

232.1

244.9


210.5

244.6

209.2

203.8


188.1

Cash collateral and settlement balances

135.2

122.5

124.7


106.9

162.6

127.7

131.2


87.2

Other assets

237.2

224.6

230.3


222.6

220.6

237.2

222.5


195.8

Total assets

1,180.1

1,137.9

1,123.1


1,101.1

1,309.4

1,170.0

1,089.8


979.3

Deposits at amortised cost

236.9

225.5

221.0


205.8

229.5

229.5

214.7


189.4

Derivative financial instrument liabilities

268.3

254.5

246.7


288.9

394.2

321.2

277.1


256.4

Risk weighted assets

219.2

216.5

216.8


215.9

230.6

227.6

213.5


200.7












Performance measures











Return on average allocated tangible equity

9.2%

10.0%

15.2%


5.4%

11.9%

7.1%

17.1%


9.7%

Average allocated tangible equity (£bn)

31.5

31.8

31.8


33.7

34.0

32.7

30.8


28.7

Cost: income ratio

65%

63%

55%


77%

55%

79%

57%


66%

Loan loss rate (bps)

(6)

(4)

10


13

13

20

(12)


(29)

Net interest margin

3.65%

3.98%

3.95%


3.73%

3.56%

2.88%

2.52%


2.67%























Analysis of total income

£m

£m

£m


£m

£m

£m

£m


£m

FICC

1,147

1,186

1,788


976

1,546

1,529

1,644


546

Equities

675

563

704


440

246

1,411

1,052


501

Global Markets

1,822

1,749

2,492


1,416

1,792

2,940

2,696


1,047

Advisory

80

130

212


197

150

236

185


287

Equity capital markets

62

69

50


40

42

37

47


158

Debt capital markets

233

273

341


243

341

281

416


511

Investment Banking fees

375

472

603


480

533

554

648


956

Corporate lending

172

168

95


(128)

(181)

(47)

125


176

Transaction banking

713

773

786


808

677

586

469


453

Corporate

885

941

881


680

496

539

594


629

Total income

3,082

3,162

3,976


2,576

2,821

4,033

3,938


2,632

 

1

The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Analysis of Barclays International






















Consumer, Cards and Payments

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q421

Income statement information

£m

£m

£m


£m

£m

£m

£m


£m

Net interest income

955

874

889


918

891

619

551


522

Net fee, commission, trading and other income

405

404

417


368

353

464

335


356

Total income

1,360

1,278

1,306


1,286

1,244

1,083

886


878

Operating costs

(801)

(763)

(754)


(747)

(733)

(667)

(584)


(598)

UK bank levy

-

-

-


(7)

-

-

-


(6)

Litigation and conduct

(17)

(32)

-


(12)

(102)

(5)

(195)


(25)

Total operating expenses

(818)

(795)

(754)


(766)

(835)

(672)

(779)


(629)

Other net income

1

5

3


3

10

5

8


2

Profit before impairment

543

488

555


523

419

416

115


251

Credit impairment charges

(378)

(288)

(371)


(287)

(249)

(144)

(134)


(96)

Profit/(loss) before tax

165

200

184


236

170

272

(19)


155

Attributable profit/(loss)

127

155

139


171

121

204

(16)


123












Balance sheet information

£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Loans and advances to customers at amortised cost

42.9

41.7

41.8


43.2

43.4

40.2

34.4


33.0

Total assets

93.0

88.5

88.3


80.2

82.0

80.6

69.2


64.8

Deposits at amortised cost

81.3

79.5

80.6


81.8

83.7

77.9

71.4


69.4

Risk weighted assets

39.9

38.1

38.2


38.9

38.7

36.2

31.6


30.2












Performance measures











Return on average allocated tangible equity

9.6%

11.8%

10.5%


13.0%

9.5%

17.8%

(1.5)%


11.7%

Average allocated tangible equity (£bn)

5.3

5.3

5.3


5.2

5.1

4.6

4.3


4.2

Cost: income ratio

60%

62%

58%


60%

67%

62%

88%


72%

Loan loss rate (bps)

321

255

332


245

211

132

145


105

Net interest margin

8.88%

8.25%

8.42%


8.40%

8.41%

6.68%

6.56%


6.29%























Analysis of total income

£m

£m

£m


£m

£m

£m

£m


£m

International Cards and Consumer Bank

890

835

900


860

824

691

538


552

Private Bank

331

295

258


285

270

245

214


200

Payments

139

148

148


141

150

147

134


126

Total income

1,360

1,278

1,306


1,286

1,244

1,083

886


878

 

Head Office












Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q421

Income statement information

£m

£m

£m


£m

£m

£m

£m


£m

Net interest income

14

(120)

81


(324)

10

-

66


(38)

Net fee, commission and other income

(71)

4

(87)


293

(40)

(132)

(43)


(11)

Total income

(57)

(116)

(6)


(31)

(30)

(132)

23


(49)

Operating costs

(75)

(82)

(63)


(97)

(94)

(60)

(85)


(152)

UK bank levy

-

-

-


(17)

-

-

-


-

Litigation and conduct

1

(5)

-


1

(54)

1

(1)


(3)

Total operating expenses

(74)

(87)

(63)


(113)

(148)

(59)

(86)


(155)

Other net income/(expenses)

6

(3)

(8)


4

(10)

2

(18)


11

Loss before impairment

(125)

(206)

(77)


(140)

(188)

(189)

(81)


(193)

Credit impairment (charges)/releases

(16)

(2)

(7)


(13)

(5)

9

8


(5)

Loss before tax

(141)

(208)

(84)


(153)

(193)

(180)

(73)


(198)

Attributable loss

(105)

(159)

(80)


(63)

(173)

(170)

(292)


(159)












Balance sheet information

£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Total assets

18.7

18.5

19.1


19.2

18.7

19.8

19.9


19.0

Risk weighted assets1

9.5

9.3

8.8


8.6

8.2

8.6

11.0


11.0

Period end allocated tangible equity1

1.0

(1.5)

0.2


(0.2)

(3.5)

1.1

3.6


5.5












Performance measures1











Average allocated tangible equity (£bn)

(0.4)

(0.6)

0.2


(2.4)

(0.4)

1.7

3.6


5.1

 

1

The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Performance Management

 

Margins and balances


Nine months ended 30.09.23

Nine months ended 30.09.22


Net interest income

Average customer assets

Net interest margin

Net interest income

Average customer assets

Net interest margin


£m

£m

%

£m

£m

%

Barclays UK

4,856

206,338

3.15

4,293

206,308

2.78

Corporate and Investment Bank

1,582

54,770

3.86

1,241

54,960

3.02

Consumer, Cards and Payments

2,718

42,674

8.52

2,061

37,481

7.35

Barclays International

4,300

97,444

5.90

3,302

92,441

4.78

Barclays Group

9,156

303,782

4.03

7,595

298,749

3.40

Other1

414



236



Total Barclays Group net interest income

9,570



7,831



 

1

Other comprises net interest income from Markets within Barclays International and Head Office including hedge accounting.

 

The Barclays Group NIM has increased 63bps from 3.40% in Q322 to 4.03% in Q323, driven by the higher interest rate environment and continued structural hedge income momentum across the Group as well as higher balances in CC&P including the Gap portfolio acquisition, partially offset by product dynamics in deposits and mortgages.

 

The Group's combined product and equity structural hedge notional amount at September 2023 was £252bn (June 2023: £256bn), with an average duration of close to 2.5 years (2022: average duration close to 3 years). Gross structural hedge contributions of £2,609m (Q322: £1,487m) and net structural hedge contributions of £(5,964)m (Q322: £(361)m) are included in Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.

 

Quarterly analysis










Q323

Q223

Q123

Q422

Q322

Net interest income

£m

£m

£m

£m

£m

Barclays UK

1,578

1,660

1,618

1,600

1,561

Corporate and Investment Bank

491

540

551

556

529

Consumer, Cards and Payments

955

874

889

918

891

Barclays International

1,446

1,414

1,440

1,474

1,420

Barclays Group

3,024

3,074

3,058

3,074

2,981







Average customer assets

£m

£m

£m

£m

£m

Barclays UK

205,693

207,073

206,241

204,941

205,881

Corporate and Investment Bank

53,290

54,417

56,612

59,146

58,891

Consumer, Cards and Payments

42,678

42,503

42,840

43,319

42,019

Barclays International

95,968

96,920

99,452

102,465

100,910

Barclays Group

301,661

303,993

305,693

307,406

306,791







Net interest margin

%

%

%

%

%

Barclays UK

3.04

3.22

3.18

3.10

3.01

Corporate and Investment Bank

3.65

3.98

3.95

3.73

3.56

Consumer, Cards and Payments

8.88

8.25

8.42

8.40

8.41

Barclays International

5.98

5.85

5.87

5.71

5.58

Barclays Group

3.98

4.06

4.06

3.97

3.85

 

Credit Risk

 

Taskforce on Disclosures about Expected Credit Losses (DECL)

 

The latest DECL III Taskforce recommendation for the minimum product groupings and geographical breakdown have been adopted in the credit risk performance section for this period and the prior period comparatives have been aligned accordingly. The Group intends to adopt further enhancements in future periods.

 

Loans and advances at amortised cost by geography

 

Total loans and advances at amortised cost in the credit risk performance section includes loans and advances at amortised cost to banks and loans and advances at amortised cost to customers.

 

The table below presents a product and geographical breakdown by stages of loans and advances at amortised cost. Also included are stage allocation of debt securities and off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio as at 30 September 2023.

 

Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For corporate portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.

 


Gross exposure


Impairment allowance


Stage 1

Stage 2

Stage 3

Total


Stage 1

Stage 2

Stage 3

Total

As at 30.09.23

£m

£m

£m

£m


£m

£m

£m

£m

Retail mortgages

149,754

17,865

1,466

169,085


57

105

105

267

Retail credit cards

7,755

2,280

201

10,236


161

367

117

645

Retail other

6,913

1,171

305

8,389


58

133

155

346

Corporate loans1

54,223

8,744

1,759

64,726


193

211

361

765

Total UK

218,645

30,060

3,731

252,436


469

816

738

2,023

Retail mortgages

4,467

353

709

5,529


6

32

327

365

Retail credit cards

23,695

3,641

1,471

28,807


381

1,161

1,170

2,712

Retail other

3,175

349

263

3,787


20

36

88

144

Corporate loans

60,455

5,041

805

66,301


90

177

245

512

Total Rest of the World

91,792

9,384

3,248

104,424


497

1,406

1,830

3,733

Total loans and advances at amortised cost

310,437

39,444

6,979

356,860


966

2,222

2,568

5,756

Debt securities

51,116

3,237

-

54,353


21

23

-

44

Total loans and advances at amortised cost including debt securities

361,553

42,681

6,979

411,213


987

2,245

2,568

5,800

Off-balance sheet loan commitments and financial guarantee contracts2

383,040

25,419

1,264

409,723


173

336

45

554

Total3,4

744,593

68,100

8,243

820,936


1,160

2,581

2,613

6,354












Net exposure


Coverage ratio


Stage 1

Stage 2

Stage 3

Total


Stage 1

Stage 2

Stage 3

Total

As at 30.09.23

£m

£m

£m

£m


%

%

%

%

Retail mortgages

149,697

17,760

1,361

168,818


-

0.6

7.2

      0.2    

Retail credit cards

7,594

1,913

84

9,591


2.1

16.1

58.2

      6.3    

Retail other

6,855

1,038

150

8,043


0.8

11.4

50.8

      4.1    

Corporate loans1

54,030

8,533

1,398

63,961


0.4

2.4

20.5

      1.2    

Total UK

218,176

29,244

2,993

250,413


0.2

2.7

19.8

      0.8    

Retail mortgages

4,461

321

382

5,164


0.1

9.1

46.1

      6.6    

Retail credit cards

23,314

2,480

301

26,095


1.6

31.9

79.5

      9.4    

Retail other

3,155

313

175

3,643


0.6

10.3

33.5

      3.8    

Corporate loans

60,365

4,864

560

65,789


0.1

3.5

30.4

      0.8    

Total Rest of the World

91,295

7,978

1,418

100,691


0.5

15.0

56.3

      3.6    

Total loans and advances at amortised cost

309,471

37,222

4,411

351,104


0.3

5.6

36.8

      1.6    

Debt securities

51,095

3,214

-

54,309


-

0.7

-

      0.1    

Total loans and advances at amortised cost including debt securities

360,566

40,436

4,411

405,413


0.3

5.3

36.8

      1.4    

Off-balance sheet loan commitments and financial guarantee contracts2

382,867

25,083

1,219

409,169


-

1.3

3.6

      0.1    

Total3,4

743,433

65,519

5,630

814,582


0.2

3.8

31.7

      0.8    

 

1

Includes Business Banking, which has a gross exposure of £15.9bn and an impairment allowance of £445m. This comprises £110m impairment allowance on £10.1bn Stage 1 exposure, £82m on £4.4bn Stage 2 exposure and £253m on £1.4bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 0.7%.

2

Excludes loan commitments and financial guarantees of £15.3bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £216.3bn and impairment allowance of £165m. This comprises £20m impairment allowance on £215.1bn Stage 1 exposure, £9m on £1.0bn Stage 2 exposure and £136m on £147m Stage 3 exposure.

4

The annualised loan loss rate is 43bps after applying the total impairment charge of £1,329m.

 


Gross exposure


Impairment allowance


Stage 1

Stage 2

Stage 3

Total


Stage 1

Stage 2

Stage 3

Total

As at 31.12.22

£m

£m

£m

£m


£m

£m

£m

£m

Retail mortgages

145,821

17,735

1,481

165,037


21

49

58

128

Retail credit cards

7,119

2,569

251

9,939


127

493

137

757

Retail other

8,202

1,197

293

9,692


72

138

145

355

Corporate loans1

55,187

12,528

2,008

69,723


317

264

360

941

Total UK

216,329

34,029

4,033

254,391


537

944

700

2,181

Retail mortgages

7,851

465

933

9,249


8

24

356

388

Retail credit cards

22,669

3,880

1,129

27,678


331

1,127

818

2,276

Retail other

5,268

271

427

5,966


28

28

163

219

Corporate loans

56,704

4,290

564

61,558


144

160

182

486

Total Rest of the World

92,492

8,906

3,053

104,451


511

1,339

1,519

3,369

Total loans and advances at amortised cost

308,821

42,935

7,086

358,842


1,048

2,283

2,219

5,550

Debt securities

41,724

3,805

-

45,529


9

33

-

42

Total loans and advances at amortised cost including debt securities

350,545

46,740

7,086

404,371


1,057

2,316

2,219

5,592

Off-balance sheet loan commitments and financial guarantee contracts2

372,945

30,694

1,180

404,819


245

315

23

583

Total3,4

723,490

77,434

8,266

809,190


1,302

2,631

2,242

6,175
















Net exposure


Coverage ratio


Stage 1

Stage 2

Stage 3

Total


Stage 1

Stage 2

Stage 3

Total

As at 31.12.22

£m

£m

£m

£m


%

%

%

%

Retail mortgages

145,800

17,686

1,423

164,909


-

0.3

3.9

0.1

Retail credit cards

6,992

2,076

114

9,182


1.8

19.2

54.6

7.6

Retail other

8,130

1,059

148

9,337


0.9

11.5

49.5

3.7

Corporate loans1

54,870

12,264

1,648

68,782


0.6

2.1

17.9

1.3

Total UK

215,792

33,085

3,333

252,210


0.2

2.8

17.4

0.9

Retail mortgages

7,843

441

577

8,861


0.1

5.2

38.2

4.2

Retail credit cards

22,338

2,753

311

25,402


1.5

29.0

72.5

8.2

Retail other

5,240

243

264

5,747


0.5

10.3

38.2

3.7

Corporate loans

56,560

4,130

382

61,072


0.3

3.7

32.3

0.8

Total Rest of the World

91,981

7,567

1,534

101,082


0.6

15.0

49.8

3.2

Total loans and advances at amortised cost

307,773

40,652

4,867

353,292


0.3

5.3

31.3

1.5

Debt securities

41,715

3,772

-

45,487


-

0.9

-

0.1

Total loans and advances at amortised cost including debt securities

349,488

44,424

4,867

398,779


0.3

5.0

31.3

1.4

Off-balance sheet loan commitments and financial guarantee contracts2

372,700

30,379

1,157

404,236


0.1

1.0

1.9

0.1

Total3,4

722,188

74,803

6,024

803,015


0.2

3.4

27.1

0.8

 

1

Includes Business Banking, which has a gross exposure of £18.1bn and an impairment allowance of £519m. This comprises £149m impairment allowance on £10.5bn Stage 1 exposure, £121m on £6.0bn Stage 2 exposure and £249m on £1.6bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 0.8%.

2

Excludes loan commitments and financial guarantees of £14.9bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn and impairment allowance of £163m. This comprises £10m impairment allowance on £178.4bn Stage 1 exposure, £9m on £1.5bn Stage 2 exposure and £144m on £149m Stage 3 exposure.

4

The annualised loan loss rate is 30bps after applying the total impairment charge of £1,220m.

 

Loans and advances at amortised cost by product

 

The table below presents a product breakdown by stages of loans and advances at amortised cost. Also included is a breakdown of Stage 2 past due balances.

 



Stage 2



As at 30.09.23

Stage 1

Not past due

<=30 days past due

>30 days past due

Total

Stage 3

Total

Gross exposure

£m

£m

£m

£m

£m

£m

£m

Retail mortgages

        154,221

          15,417

            1,935

               866

          18,218

            2,175

        174,614

Retail credit cards

          31,450

            5,226

               386

               309

            5,921

            1,672

          39,043

Retail other

          10,088

            1,313

               125

                 82

            1,520

               568

          12,176

Corporate loans

        114,678

          13,556

               153

                 76

          13,785

            2,564

        131,027

Total

       310,437

         35,512

           2,599

           1,333

         39,444

           6,979

       356,860









Impairment allowance








Retail mortgages

                 63

                 92

                 23

                 22

               137

               432

               632

Retail credit cards

               542

            1,180

               158

               190

            1,528

            1,287

            3,357

Retail other

                 78

               121

                 21

                 27

               169

               243

               490

Corporate loans

               283

               367

                 13

                   8

               388

               606

            1,277

Total

              966

           1,760

              215

              247

           2,222

           2,568

           5,756









Net exposure








Retail mortgages

        154,158

          15,325

            1,912

               844

          18,081

            1,743

        173,982

Retail credit cards

          30,908

            4,046

               228

               119

            4,393

               385

          35,686

Retail other

          10,010

            1,192

               104

                 55

            1,351

               325

          11,686

Corporate loans

        114,395

          13,189

               140

                 68

          13,397

            1,958

        129,750

Total

       309,471

         33,752

           2,384

           1,086

         37,222

           4,411 

       351,104









Coverage ratio

%

%

%

%

%

%

%

Retail mortgages

-

0.6

1.2

2.5

0.8

19.9

0.4

Retail credit cards

1.7

22.6

40.9

61.5

25.8

77.0

8.6

Retail other

0.8

9.2

16.8

32.9

11.1

42.8

4.0

Corporate loans

0.2

2.7

8.5

10.5

2.8

23.6

1.0

Total

0.3

5.0

8.3

18.5

5.6

36.8

1.6

 

As at 31.12.22








Gross exposure

£m

£m

£m

£m

£m

£m

£m

Retail mortgages

        153,672

          15,990

            1,684

               526

          18,200

            2,414

        174,286

Retail credit cards

          29,788

            5,731

               284

               434

            6,449

            1,380

          37,617

Retail other

          13,470

            1,232

               104

               132

            1,468

               720

          15,658

Corporate loans

        111,891 

          16,552

               159

               107

          16,818

            2,572

        131,281

Total

       308,821

         39,505

           2,231

           1,199

         42,935

           7,086

       358,842









Impairment allowance








Retail mortgages

                 29

                 53

                 11

                   9

                 73

               414

               516

Retail credit cards

               458

            1,334

               100

               186

            1,620

               955

            3,033

Retail other

               100

               118

                 22

                 26

               166

               308

               574

Corporate loans

               461

               401

                 13

                 10

               424

               542

            1,427

Total

           1,048

           1,906

              146

              231

           2,283

           2,219

           5,550









Net exposure








Retail mortgages

        153,643

          15,937

            1,673

               517

          18,127

            2,000

        173,770

Retail credit cards

          29,330

            4,397

               184

               248

            4,829

               425

          34,584

Retail other

          13,370

            1,114

                 82

               106

            1,302

               412

          15,084

Corporate loans

        111,430 

          16,151

               146

                 97

          16,394

            2,030

        129,854

Total

       307,773

         37,599

           2,085

              968

         40,652

           4,867

       353,292









Coverage ratio

%

%

%

%

%

%

%

Retail mortgages

-

0.3

0.7

1.7

0.4

17.1

0.3

Retail credit cards

1.5

23.3

35.2

42.9

25.1

69.2

8.1

Retail other

0.7

9.6

21.2

19.7

11.3

42.8

3.7

Corporate loans

0.4

2.4

8.2

9.3

2.5

21.1

1.1

Total

0.3

4.8

6.5

19.3

5.3

31.3

1.5

 

 

Measurement uncertainty

 

Scenarios used to calculate the Group's ECL charge were refreshed in Q323 with the Baseline scenario reflecting the latest consensus macroeconomic forecasts available at the time of the scenario refresh. In the Baseline scenario, although the outlook in major economies has improved somewhat since last year, GDP growth remains weak in the coming quarters and beyond, as tight monetary policy continues to restrain growth. Consumer price inflation eases over 2023 as base effects, supply chain pressures and lower energy prices provide some downward pressure. UK and US unemployment rates increase only gradually in the coming quarters, peaking at 4.5% in Q424 and reaching 4.4% in Q324 respectively. Central banks continue raising interest rates, with both the UK bank rate and the US federal funds rate reaching their peaks at 6.0% and 5.5% respectively during 2023.

 

The Downside 2 scenario is broadly aligned to the previous scenario refresh. Inflation rates rise again as energy prices suddenly surge again amid renewed geopolitical risks. Inflation becomes entrenched and inflation expectations go up, contributing to higher pressure on wage growth. Central banks are forced to raise interest rates sharply with the UK bank rate reaching 8% and the US federal funds rate peaking at 7%. Weakened businesses lay off workers and consumers stop spending exacerbating the downward stress. Unemployment peaks at 8.5% in the UK and 9.8% in the US. Given already stretched valuations, the sharp increase in borrowing costs sees house prices decrease significantly. In the Upside scenarios, lower energy prices add downward pressure on prices globally, while recovering labour force participation limits wage growth. As a result of easing inflation, central banks lower interest rates to support the economic recovery.

 

The methodology for estimating scenario probability weights involves simulating a range of future paths for UK and US GDP using historical data with the five scenarios mapped against the distribution of these future paths. The median is centred around the Baseline with scenarios further from the Baseline attracting a lower weighting before the five weights are normalised to total 100%. The decrease in the Downside and Upside weightings and the increase in the Baseline weighting reflected a closer alignment between actual GDP and Baseline, increasing the expected likelihood of the Baseline relative to the other scenarios. An improving economic outlook moved the Baseline US GDP paths further from the Downside scenarios, further reducing the Downside weights.

 

The economic uncertainty adjustments of £0.3bn (30 June 2023: £0.3bn) have been applied as overlays to the modelled ECL output. These adjustments consist of a customer and client uncertainty provision of £0.3bn (30 June 2023: £0.2bn) which has been applied to customers and clients considered most vulnerable to affordability pressures, and a model uncertainty adjustment of £nil (30 June 2023: £0.1bn).

 

The following tables show the key macroeconomic variables used in the five scenarios (5 year annual paths) and the probability weights applied to each scenario.

 

Macroeconomic variables used in the calculation of ECL

As at 30.09.23

2023

2024

2025

2026

2027

Baseline

%

%

%

%

%

UK GDP1

0.4

0.4

1.4

2.0

2.0

UK unemployment2

4.1

4.4

4.3

4.5

4.8

UK HPI3

(5.8)

(2.7)

1.9

3.8

7.3

UK bank rate

5.1

5.9

5.2

4.7

4.4

US GDP1

2.0

0.9

1.7

1.8

1.8

US unemployment4

3.6

4.3

4.4

4.4

4.4

US HPI5

0.9

1.9

3.1

3.1

3.1

US federal funds rate

5.2

4.9

4.1

3.8

3.8







Downside 2






UK GDP1

0.2

(4.2)

(2.1)

2.5

2.1

UK unemployment2

4.2

6.9

8.4

7.8

7.2

UK HPI3

(6.4)

(20.5)

(17.9)

(1.2)

10.2

UK bank rate

5.1

7.8

7.6

6.4

5.2

US GDP1

1.8

(3.9)

(1.9)

2.6

2.3

US unemployment4

3.8

7.8

9.7

8.8

7.4

US HPI5

0.6

(4.2)

(3.8)

0.7

5.2

US federal funds rate

5.3

6.9

6.8

5.4

4.4







Downside 1






UK GDP1

0.3

(1.9)

(0.3)

2.2

2.0

UK unemployment2

4.1

5.7

6.3

6.2

6.0

UK HPI3

(6.1)

(11.9)

(8.4)

1.3

8.8

UK bank rate

5.1

6.8

6.4

5.6

4.9

US GDP1

1.9

(1.5)

(0.1)

2.2

2.1

US unemployment4

3.7

6.1

7.0

6.6

5.9

US HPI5

0.8

(1.2)

(0.4)

1.9

4.2

US federal funds rate

5.3

5.9

5.3

4.8

4.1







Upside 2






UK GDP1

0.8

4.0

3.3

2.8

2.4

UK unemployment2

4.0

3.7

3.5

3.6

3.6

UK HPI3

(3.2)

9.4

6.2

4.4

6.0

UK bank rate

4.7

3.6

2.6

2.5

2.5

US GDP1

2.3

3.9

3.2

2.8

2.8

US unemployment4

3.5

3.4

3.6

3.6

3.6

US HPI5

2.6

5.0

5.2

4.9

4.9

US federal funds rate

4.9

3.5

2.9

2.8

2.8







Upside 1






UK GDP1

0.6

2.2

2.4

2.4

2.2

UK unemployment2

4.1

4.0

3.9

4.0

4.2

UK HPI3

(4.5)

3.2

4.0

4.1

6.6

UK bank rate

4.9

4.8

3.9

3.5

3.4

US GDP1

2.2

2.4

2.5

2.3

2.3

US unemployment4

3.6

3.9

4.0

4.0

4.0

US HPI5

1.7

3.5

4.1

4.0

4.0

US federal funds rate

5.1

4.3

3.6

3.4

3.3

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

As at 30.06.23

2023

2024

2025

2026

2027

Baseline

%

%

%

%

%

UK GDP1

0.3

0.9

1.6

1.8

1.9

UK unemployment2

4.1

4.4

4.2

4.2

4.2

UK HPI3

(6.1)

(1.3)

2.0

4.3

5.7

UK bank rate

4.8

4.6

3.9

3.8

3.5

US GDP1

1.1

0.7

2.0

2.0

2.0

US unemployment4

3.8

4.6

4.6

4.6

4.6

US HPI5

(0.7)

3.6

2.4

2.7

2.7

US federal funds rate

5.0

3.7

3.0

2.8

3.0







Downside 2






UK GDP1

(0.5)

(5.0)

(0.4)

2.5

1.9

UK unemployment2

4.4

7.8

8.3

7.7

7.1

UK HPI3

(10.2)

(20.5)

(17.7)

5.6

8.2

UK bank rate

5.5

8.0

7.3

6.1

4.8

US GDP1

0.5

(4.8)

(0.3)

2.8

2.1

US unemployment4

4.5

8.7

9.6

8.5

7.0

US HPI5

(1.8)

(3.7)

(4.2)

2.6

4.8

US federal funds rate

5.7

7.0

6.5

5.1

4.2







Downside 1






UK GDP1

(0.1)

(2.1)

0.6

2.2

1.9

UK unemployment2

4.2

6.1

6.2

5.9

5.6

UK HPI3

(8.1)

(11.3)

(8.2)

5.0

7.0

UK bank rate

5.2

6.1

5.6

4.8

4.1

US GDP1

0.8

(2.0)

0.8

2.4

2.0

US unemployment4

4.1

6.7

7.1

6.5

5.8

US HPI5

(1.2)

(0.1)

(0.9)

2.7

3.8

US federal funds rate

5.2

4.9

4.5

4.3

3.8







Upside 2






UK GDP1

1.2

4.1

3.2

2.6

2.3

UK unemployment2

3.9

3.6

3.5

3.6

3.6

UK HPI3

0.4

10.6

4.8

4.2

3.8

UK bank rate

4.4

3.3

2.5

2.5

2.5

US GDP1

2.2

3.9

3.0

2.8

2.8

US unemployment4

3.4

3.5

3.6

3.6

3.6

US HPI5

2.5

5.5

4.6

4.5

4.5

US federal funds rate

4.7

3.2

2.2

2.0

2.0







Upside 1






UK GDP1

0.8

2.5

2.4

2.2

2.1

UK unemployment2

4.0

4.0

3.9

3.9

3.9

UK HPI3

(2.9)

4.5

3.4

4.3

4.7

UK bank rate

4.6

4.0

3.1

3.0

3.0

US GDP1

1.6

2.3

2.5

2.4

2.4

US unemployment4

3.6

4.1

4.1

4.1

4.1

US HPI5

0.9

4.6

3.5

3.6

3.6

US federal funds rate

4.8

3.4

2.6

2.5

2.5

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

As at 31.12.22

2022

2023

2024

2025

2026

Baseline

%

%

%

%

%

UK GDP1

3.3

(0.8)

0.9

1.8

1.9

UK unemployment2

3.7

4.5

4.4

4.1

4.2

UK HPI3

8.4

(4.7)

(1.7)

2.2

2.2

UK bank rate

1.8

4.4

4.1

3.8

3.4

US GDP1

1.8

0.5

1.2

1.5

1.5

US unemployment4

3.7

4.3

4.7

4.7

4.7

US HPI5

11.2

1.8

1.5

2.3

2.4

US federal funds rate

2.1

4.8

3.6

3.1

3.0







Downside 2






UK GDP1

3.3

(3.4)

(3.8)

2.0

2.3

UK unemployment2

3.7

6.0

8.4

8.0

7.4

UK HPI3

8.4

(18.3)

(18.8)

(7.7)

8.2

UK bank rate

1.8

7.3

7.9

6.6

5.5

US GDP1

1.8

(2.7)

(3.4)

2.0

2.6

US unemployment4

3.7

6.0

8.5

8.1

7.1

US HPI5

11.2

(3.1)

(4.0)

(1.9)

4.8

US federal funds rate

2.1

6.6

6.9

5.8

4.6







Downside 1






UK GDP1

3.3

(2.1)

(1.5)

1.9

2.1

UK unemployment2

3.7

5.2

6.4

6.0

5.8

UK HPI3

8.4

(11.7)

(10.6)

(2.8)

5.2

UK bank rate

1.8

5.9

6.1

5.3

4.6

US GDP1

1.8

(1.1)

(1.1)

1.7

2.1

US unemployment4

3.7

5.1

6.6

6.4

5.9

US HPI5

11.2

(0.7)

(1.3)

0.2

3.6

US federal funds rate

2.1

5.8

5.4

4.4

3.9







Upside 2






UK GDP1

3.3

2.8

3.7

2.9

2.4

UK unemployment2

3.7

3.5

3.4

3.4

3.4

UK HPI3

8.4

8.7

7.5

4.4

4.2

UK bank rate

1.8

3.1

2.6

2.5

2.5

US GDP1

1.8

3.3

3.5

2.8

2.8

US unemployment4

3.7

3.3

3.3

3.3

3.3

US HPI5

11.2

5.8

5.1

4.5

4.5

US federal funds rate

2.1

3.6

2.9

2.8

2.8







Upside 1






UK GDP1

3.3

1.0

2.3

2.4

2.1

UK unemployment2

3.7

4.0

3.9

3.8

3.8

UK HPI3

8.4

1.8

2.9

3.3

3.2

UK bank rate

1.8

3.5

3.3

3.0

2.8

US GDP1

1.8

1.9

2.3

2.2

2.2

US unemployment4

3.7

3.8

4.0

4.0

4.0

US HPI5

11.2

3.8

3.3

3.4

3.4

US federal funds rate

2.1

3.9

3.4

3.0

3.0

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end

 

Scenario probability weighting

Upside 2

Upside 1

Baseline

Downside 1

Downside 2


%

%

%

%

%

As at 30.09.23






Scenario probability weighting

12.3

24.4

41.5

15.1

6.7

As at 30.06.23






Scenario probability weighting

               13.0

               24.7

               40.2

               15.2

                 6.9

As at 31.12.22






Scenario probability weighting

               10.9

               23.1

               39.4

               17.6

                 9.0

 

 

Risk

 

Regulatory minimum requirements

 

Capital

 

The Group's Overall Capital Requirement for CET1 is 11.8% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and a 0.9% Countercyclical Capital Buffer (CCyB).

 

The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. Following the Financial Policy Committee (FPC) announcement on 5 July 2022, the UK CCyB increased from 1% to 2% with effect from 5 July 2023. The buffer rates set by other national authorities for non-UK exposures are not currently material.

 

The Group's Pillar 2A requirement as per the PRA's Individual Capital Requirement is 4.3% of which at least 56.25% needs to be met with CET1 capital, equating to 2.4% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.

 

The Group's CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA buffer.

 

Leverage

 

The Group is subject to a UK leverage ratio requirement of 4.1%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.3%. The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.

 

MREL

 

The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.3% Pillar 2A equating to 24.7% of RWAs; and (ii) 6.75% of leverage exposures. In addition, the higher of regulatory capital and leverage buffers apply. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including the above mentioned confidential institution-specific PRA buffer, will effectively be applied above MREL requirements.

 

In the disclosures that follow, references to CRR, as amended by CRR II, mean the capital regulatory requirements, as they form part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

Capital ratios1,2

As at 30.09.23

As at 30.06.23

As at 31.12.22

CET1

14.0%

13.8%

13.9%

T1

17.5%

17.9%

17.9%

Total regulatory capital

20.0%

20.5%

20.8%

MREL ratio as a percentage of total RWAs

33.4%

32.9%

33.5%





Own funds and eligible liabilities

£m

£m

£m

Total equity excluding non-controlling interests per the balance sheet

68,315

67,669

68,292

Less: other equity instruments (recognised as AT1 capital)

(11,857)

(13,759)

(13,284)

Adjustment to retained earnings for foreseeable ordinary share dividends

(497)

(622)

(787)

Adjustment to retained earnings for foreseeable repurchase of shares

(223)

-

-

Adjustment to retained earnings for foreseeable other equity coupons

(45)

(39)

(37)





Other regulatory adjustments and deductions




Additional value adjustments (PVA)

(1,630)

(1,800)

(1,726)

Goodwill and intangible assets

(8,243)

(8,584)

(8,224)

Deferred tax assets that rely on future profitability excluding temporary differences

(1,480)

(1,372)

(1,500)

Fair value reserves related to gains or losses on cash flow hedges

6,421

7,992

7,237

Excess of expected losses over impairment

(292)

(228)

(119)

Gains or losses on liabilities at fair value resulting from own credit

(142)

(116)

(620)

Defined benefit pension fund assets

(2,960)

(2,995)

(3,430)

Direct and indirect holdings by an institution of own CET1 instruments

(20)

(20)

(20)

Adjustment under IFRS 9 transitional arrangements

290

206

700

Other regulatory adjustments

321

308

396

CET1 capital

47,958

46,640

46,878





AT1 capital




Capital instruments and related share premium accounts

11,857

13,759

13,284

Other regulatory adjustments and deductions

(60)

(60)

(60)

AT1 capital

11,797

13,699

13,224





T1 capital

59,755

60,339

60,102





T2 capital




Capital instruments and related share premium accounts

8,126

8,212

9,000

Qualifying T2 capital (including minority interests) issued by subsidiaries

757

769

1,095

Credit risk adjustments (excess of impairment over expected losses)

58

71

35

Other regulatory adjustments and deductions

(160)

(160)

(160)

Total regulatory capital

68,536

69,231

70,072





Less : Ineligible T2 capital (including minority interests) issued by subsidiaries

(757)

(769)

(1,095)

Eligible liabilities

46,477

42,559

43,851





Total own funds and eligible liabilities3

114,256

111,021

112,828





Total RWAs

341,868

336,946

336,518

 

1

CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments.

2

The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.9%, with £47.7bn of CET1 capital and £341.8bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.

3

As at 30 September 2023, the Group's MREL requirement, excluding the PRA buffer, was to hold £101.1bn of own funds and eligible liabilities equating to 29.6% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer

 

Movement in CET1 capital

Three months ended 30.09.23

Nine months ended 30.09.23


£m

£m

Opening CET1 capital

46,640

46,878




Profit for the period attributable to equity holders

1,533

5,151

Own credit relating to derivative liabilities

-

8

Ordinary share dividends paid and foreseen

(298)

(920)

Purchased and foreseeable share repurchase

(750)

(1,250)

Other equity coupons paid and foreseen

(267)

(774)

Increase in retained regulatory capital generated from earnings

218

2,215




Net impact of share schemes

120

(36)

Fair value through other comprehensive income reserve

(157)

(82)

Currency translation reserve

810

(363)

Other reserves

(16)

(36)

Increase/(decrease) in other qualifying reserves

757

(517)




Pension remeasurements within reserves

(51)

(527)

Defined benefit pension fund asset deduction

35

470

Net impact of pensions

(16)

(57)




Additional value adjustments (PVA)

170

96

Goodwill and intangible assets

341

(19)

Deferred tax assets that rely on future profitability excluding those arising from temporary differences

(108)

20

Excess of expected loss over impairment

(64)

(173)

Adjustment under IFRS 9 transitional arrangements

84

(410)

Other regulatory adjustments

(64)

(75)

Increase/(decrease) in regulatory capital due to adjustments and deductions

359

(561)




Closing CET1 capital

47,958

47,958

 

CET1 capital increased £1.1bn to £48.0bn (December 2022: £46.9bn).

 

£5.2bn of capital generated from profit was partially offset by distributions of £2.9bn comprising:

 

£1.3bn of share buybacks announced with FY22 and H123 results

£0.9bn of ordinary share dividend paid and foreseen reflecting £0.4bn half year 2023 dividend paid and a £0.5bn accrual towards FY23 dividend

£0.8bn of equity coupons paid and foreseen

 

Other significant movements in the period were:

 

£0.4bn decrease in the currency translation reserve driven by the strengthening of GBP against USD since December 2022

£0.4bn decrease in IFRS 9 transitional relief primarily due to the relief applied to the pre-2020 impairment charge reducing to 0% in 2023 from 25% in 2022 and the relief applied to the post-2020 impairment charge reducing to 50% in 2023 from 75% in 2022.

 

RWAs by risk type and business


Credit risk1


Counterparty credit risk


Market Risk


Operational risk

Total RWAs


STD

IRB


STD

IRB

Settlement Risk

CVA


STD

IMA




As at 30.09.23

£m

£m


£m

£m

£m

£m


£m

£m


£m

£m

Barclays UK

11,731

49,928


160

-

-

90


215

-


11,054

73,178

Corporate and Investment Bank

38,869

69,467


17,983

21,784

123

3,108


17,542

23,253


27,093

219,222

Consumer, Cards and Payments

28,613

3,987


191

51

-

42


2

535


6,527

39,948

Barclays International

67,482

73,454


18,174

21,835

123

3,150


17,544

23,788


33,620

259,170

Head Office

4,116

6,213


-

-

-

-


-

-


(809)

9,520

Barclays Group

83,329

129,595


18,334

21,835

123

3,240


17,759

23,788


43,865

341,868

As at 30.06.23














Barclays UK

8,377

52,867


245

-

-

124


374

-


11,054

73,041

Corporate and Investment Bank

33,567

75,880


17,551

20,687

454

2,841


16,179

22,251


27,093

216,503

Consumer, Cards and Payments

26,306

4,484


202

51

-

63


3

424


6,527

38,060

Barclays International

59,873

80,364


17,753

20,738

454

2,904


16,182

22,675


33,620

254,563

Head Office

2,584

7,567


-

-

-

-


-

-


(809)

9,342

Barclays Group

70,834

140,798


17,998

20,738

454

3,028


16,556

22,675


43,865

336,946

As at 31.12.22














Barclays UK

6,836

54,752


167

-

-

72


233

-


11,023

73,083

Corporate and Investment Bank

35,738

75,413


16,814

21,449

80

3,093


13,716

22,497


27,064

215,864

Consumer, Cards and Payments

27,882

3,773


214

46

-

61


-

388


6,559

38,923

Barclays International

63,620

79,186


17,028

21,495

80

3,154


13,716

22,885


33,623

254,787

Head Office

2,636

6,843


-

-

-

-


-

-


(831)

8,648

Barclays Group

73,092

140,781


17,195

21,495

80

3,226


13,949

22,885


43,815

336,518

 

1

Credit risk RWAs of £9.8bn relating to deferred tax assets, have been reclassified from IRB to STD with no impact to total RWAs.

 

Movement analysis of RWAs

Credit risk

Counterparty credit risk

Market risk

Operational risk

Total RWAs


£m

£m

£m

£m

£m

Opening RWAs (as at 31.12.22)

213,873

41,996

36,834

43,815

336,518

Book size

(1,047)

1,901

4,749

50

5,653

Acquisitions and disposals

688

-

-

-

688

Book quality

1,466

(6)

-

-

1,460

Model updates

(2,600)

-

-

-

(2,600)

Methodology and policy

2,740

583

-

-

3,323

Foreign exchange movements1

(2,196)

(942)

(36)

-

(3,174)

Total RWA movements

(949)

1,536

4,713

50

5,350

Closing RWAs (as at 30.09.23)

212,924

43,532

41,547

43,865

341,868

 

1

Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.

 

Overall RWAs increased £5.4bn to £341.9bn (December 2022: £336.5bn).

 

Credit risk RWAs decreased £0.9bn:

 

A £1.0bn decrease in book size within CIB, partially offset by higher credit card balances within CC&P

A £1.5bn increase in book quality RWAs primarily driven by changes in risk parameters and HPI refresh within Barclays UK

A £2.6bn decrease in model updates primarily driven by capital LGD model update for the mortgage portfolio to reflect the significant decrease in repossession volume during and post the COVID pandemic

A £2.7bn increase in methodology and policy primarily driven by the recalibration of the post model adjustment (PMA) introduced to address the IRB roadmap changes.

A £2.2bn decrease as a result of foreign exchange movements primarily due to the strengthening of GBP against USD since December 2022

 

Counterparty Credit risk RWAs increased £1.5bn:

 

A £1.9bn increase in book size primarily due to increased trading activity within CIB since December 2022

 

Market risk RWAs increased £4.7bn:

 

A £4.7bn increase in book size primarily due to increased trading activity within CIB since December 2022

 

Leverage ratios1,2

As at 30.09.23

As at 30.06.23

As at 31.12.22

£m

£m

£m

UK leverage ratio3

5.0%

5.1%

5.3%

T1 capital

59,755

60,339

60,102

UK leverage exposure

1,202,417

1,183,703

1,129,973

Average UK leverage ratio

4.6%

4.8%

4.8%

Average T1 capital

58,661

60,176

60,865

Average UK leverage exposure

1,262,290

1,261,094

1,280,972

 

1

Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.

2

Fully loaded UK leverage ratio was 4.9%, with £59.5bn of T1 capital and £1,202.1bn of leverage exposure. Fully loaded average UK leverage ratio was 4.6% with £58.4bn of T1 capital and £1,262.0bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II.

3

Although the leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement as well as the G-SII ALRB and CCLB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.3bn and against the 0.3% CCLB was £3.6bn.

 

The UK leverage ratio decreased to 5.0% (December 2022: 5.3%) primarily due to a £72.4bn increase in leverage exposure to £1,202.4bn (December 2022: £1,130.0bn). This is largely driven by increased trading activity within CIB since December 2022.

 

Condensed Consolidated Financial Statements

 

Condensed consolidated income statement (unaudited)


Nine months ended 30.09.23

Nine months ended 30.09.22


£m

£m

Total income

19,780

19,155

Operating expenses excluding litigation and conduct

(11,979)

(11,209)

Litigation and conduct

(32)

(1,518)

Operating expenses

(12,011)

(12,727)

Other net income/(expenses)

7

(4)

Profit before impairment

7,776

6,424

Credit impairment charges

(1,329)

(722)

Profit before tax

6,447

5,702

Tax charge

(1,257)

(1,072)

Profit after tax

5,190

4,630




Attributable to:



Equity holders of the parent

4,385

3,987

Other equity instrument holders

766

620

Total equity holders of the parent

5,151

4,607

Non-controlling interests

39

23

Profit after tax

5,190

4,630




Earnings per share



Basic earnings per ordinary share

28.2p

24.2p

 

Condensed consolidated balance sheet (unaudited)


As at 30.09.23

As at 31.12.22

Assets

£m

£m

Cash and balances at central banks

262,800

256,351

Cash collateral and settlement balances

140,844

112,597

Debt securities at amortised cost

54,309

45,487

Loans and advances at amortised cost to banks

11,534

10,015

Loans and advances at amortised cost to customers

339,570

343,277

Reverse repurchase agreements and other similar secured lending

1,424

776

Trading portfolio assets

155,374

133,813

Financial assets at fair value through the income statement

241,142

213,568

Derivative financial instruments

282,144

302,380

Financial assets at fair value through other comprehensive income

72,638

65,062

Investments in associates and joint ventures

909

922

Goodwill and intangible assets

8,265

8,239

Current tax assets

109

385

Deferred tax assets

6,766

6,991

Other assets

13,893

13,836

Total assets

1,591,721

1,513,699




Liabilities



Deposits at amortised cost from banks

28,501

19,979

Deposits at amortised cost from customers

532,791

525,803

Cash collateral and settlement balances

129,032

96,927

Repurchase agreements and other similar secured borrowing

41,254

27,052

Debt securities in issue

102,794

112,881

Subordinated liabilities

11,220

11,423

Trading portfolio liabilities

67,189

72,924

Financial liabilities designated at fair value

326,448

271,637

Derivative financial instruments

268,634

289,620

Current tax liabilities

734

580

Deferred tax liabilities

16

16

Other liabilities

14,133

15,597

Total liabilities

1,522,746

1,444,439




Equity



Called up share capital and share premium

4,257

4,373

Other reserves

(2,124)

(2,192)

Retained earnings

54,325

52,827

Shareholders' equity attributable to ordinary shareholders of the parent

56,458

55,008

Other equity instruments

11,857

13,284

Total equity excluding non-controlling interests

68,315

68,292

Non-controlling interests

660

968

Total equity

68,975

69,260




Total liabilities and equity

1,591,721

1,513,699

 

Condensed consolidated statement of changes in equity (unaudited)


Called up share capital and share premium

Other equity instruments

Other reserves

 

 

Retained earnings

 

 

Total

Non-controlling interests1

 

Total equity

Nine months ended 30.09.2023

£m

£m

£m

£m

£m

£m

£m

Balance as at 1 January 2023

4,373

13,284

(2,192)

52,827

68,292

968

69,260

Profit after tax

-

766

-

4,385

5,151

39

5,190

Currency translation movements

-

-

(363)

-

(363)

-

(363)

Fair value through other comprehensive income reserve

-

-

(82)

-

(82)

-

(82)

Cash flow hedges

-

-

816

-

816

-

816

Retirement benefit remeasurements

-

-

-

(527)

(527)

-

(527)

Own credit

-

-

(469)

-

(469)

-

(469)

Total comprehensive income for the period

-

766

(98)

3,858

4,526

39

4,565

Employee share schemes and hedging thereof

52

-

-

407

459

-

459

Issue and redemption of other equity instruments

-

(1,426)

-

(41)

(1,467)

(312)

(1,779)

Other equity instruments coupons paid

-

(766)

-

-

(766)

-

(766)

Vesting of employee share schemes

-

-

(2)

(494)

(496)

-

(496)

Dividends paid

-

-

-

(1,210)

(1,210)

(39)

(1,249)

Repurchase of shares

(168)

-

168

(1,027)

(1,027)

-

(1,027)

Other movements

-

(1)

-

5

4

4

8

Balance as at 30 September 2023

4,257

11,857

(2,124)

54,325

68,315

660

68,975

 

Three months ended 30.09.2023

£m

£m

£m

£m

£m

£m

£m

Balance as at 1 July 2023

4,325

13,759

(4,457)

54,042

67,669

876

68,545

Profit after tax

-

259

-

1,274

1,533

9

1,542

Currency translation movements

-

-

810

-

810

-

810

Fair value through other comprehensive income reserve

-

-

(157)

-

(157)

-

(157)

Cash flow hedges

-

-

1,571

-

1,571

-

1,571

Retirement benefit remeasurements

-

-

-

(51)

(51)

-

(51)

Own credit

-

-

25

-

25

-

25

Total comprehensive income for the period

-

259

2,249

1,223

3,731

9

3,740

Employee share schemes and hedging thereof

14

-

-

36

50

-

50

Issue and redemption of other equity instruments

-

(1,926)

-

(33)

(1,959)

(219)

(2,178)

Other equity instruments coupons paid

-

(259)

-

-

(259)

-

(259)

Vesting of employee share schemes

-

-

2

(10)

(8)

-

(8)

Dividends paid

-

-

-

(417)

(417)

(9)

(426)

Repurchase of shares

(82)

-

82

(524)

(524)

-

(524)

Other movements

-

24

-

8

32

3

35

Balance as at 30 September 2023

4,257

11,857

(2,124)

54,325

68,315

660

68,975

 


As at 30.09.23

As at 31.12.22

Other Reserves

£m

£m

Currency translation reserve

4,409

4,772

Fair value through other comprehensive income reserve

(1,642)

(1,560)

Cash flow hedging reserve

(6,419)

(7,235)

Own credit reserve

(2)

467

Other reserves and treasury shares

1,530

1,364

Total

(2,124)

(2,192)

 

1

During Q323, a redemption notice was published related to the 9% Permanent Interest Bearing Capital Bonds, as a result of which £40m was transferred from non-controlling interests to subordinated liabilities ahead of redemption on 11 October 2023. This item is presented within Issue and redemption of other equity instruments.

 

Appendix: Non-IFRS Performance Measures

 

The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements, as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.

 

However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

 

Non-IFRS performance measures glossary

 

Measure

Definition

Loan: deposit ratio

Total loans and advances at amortised cost divided by total deposits at amortised cost.

Attributable profit

Profit after tax attributable to ordinary shareholders of the parent.

Period end tangible equity refers to:


Period end tangible shareholders' equity (for Barclays Group)

Shareholders' equity attributable to ordinary shareholders of the parent, adjusted for the deduction of intangible assets and goodwill

Period end allocated tangible equity (for businesses)

Allocated tangible equity is calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group's tangible shareholders' equity and the amounts allocated to businesses.

Average tangible equity refers to:


Average tangible shareholders' equity (for Barclays Group)

Calculated as the average of the previous month's period end tangible shareholders' equity and the current month's period end tangible shareholders' equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period.

Average allocated tangible equity (for businesses)

Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.

Return on tangible equity (RoTE) refers to:


Return on average tangible shareholders' equity (for Barclays Group)

Annualised Group attributable profit, as a proportion of average tangible shareholders' equity. The components of the calculation have been included on pages 41 to 42.

Return on average allocated tangible equity (for businesses)

Annualised business attributable profit, as a proportion of that business's average allocated tangible equity. The components of the calculation have been included on pages 41 to 43.

Operating expenses excluding litigation and conduct

A measure of total operating expenses excluding litigation and conduct charges.

Operating costs

A measure of total operating expenses excluding litigation and conduct charges and UK bank levy.

Cost: income ratio

Total operating expenses divided by total income.

Loan loss rate

Quoted in basis points and represents total impairment charges divided by total gross loans and advances held at amortised cost at the balance sheet date.

Net interest margin

Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 23.

Tangible net asset value per share

Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 44.

Performance measures excluding the impact of the Over-issuance of Securities

Calculated by excluding the impact of the Over-issuance of Securities from performance measures. The components of the calculations have been included on page 44.

Profit before impairment

Calculated by excluding credit impairment charges or releases from profit before tax.

 

Returns

 


Nine months ended 30.09.23


Barclays UK

Corporate and Investment Bank

Consumer, Cards and Payments

Barclays International

Head Office

Barclays Group

Return on average tangible equity

£m

£m

£m

£m

£m

£m

Attributable profit/(loss)

1,580

2,728

421

3,149

(344)

4,385









£bn

£bn

£bn

£bn

£bn

£bn

Average equity

14.0

31.7

6.2

37.9

3.6

55.5

Average goodwill and intangibles

(3.8)

-

(0.9)

(0.9)

(3.8)

(8.5)

Average tangible equity

10.2

31.7

5.3

37.0

(0.2)

47.0








Return on average tangible equity

20.6%

11.5%

10.6%

11.4%

n/m

12.5%

 


Nine months ended 30.09.22


Barclays UK

Corporate and Investment Bank

Consumer, Cards and Payments

Barclays International

Head Office

Barclays Group

Return on average tangible equity

£m

£m

£m

£m

£m

£m

Attributable profit/(loss)

1,403

2,910

309

3,219

(635)

3,987









£bn

£bn

£bn

£bn

£bn

£bn

Average equity

13.6

32.5

5.6

38.1

5.2

56.9

Average goodwill and intangibles

(3.6)

-

(0.9)

(0.9)

(3.6)

(8.1)

Average tangible equity

10.0

32.5

4.7

37.2

1.6

48.8








Return on average tangible equity

18.7%

11.9%

8.9%

11.5%

n/m

10.9%

 

Barclays Group











Return on average tangible shareholders' equity

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q4211

£m

£m

£m


£m

£m

£m

£m


£m

Attributable profit

1,274

1,328

1,783


1,036

1,512

1,071

1,404


1,079













£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Average shareholders' equity

55.1

55.4

55.9


54.9

56.8

57.1

56.9


56.1

Average goodwill and intangibles

(8.6)

(8.7)

(8.3)


(8.2)

(8.2)

(8.1)

(8.1)


(8.1)

Average tangible shareholders' equity

46.5

46.7

47.6


46.7

48.6

49.0

48.8


48.0












Return on average tangible shareholders' equity

11.0%

11.4%

15.0%


8.9%

12.5%

8.7%

11.5%


9.0%












 

Barclays UK











Return on average allocated tangible equity

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q421

£m

£m

£m


£m

£m

£m

£m


£m

Attributable profit

531

534

515


549

458










£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Average allocated equity

14.0

14.2

13.9


13.5

13.6


Average goodwill and intangibles

(3.9)

(4.0)

(3.6)


(3.5)

(3.6)

(3.6)

(3.6)


(3.6)

Average allocated tangible equity

10.1

10.2

10.3


9.9

10.0













Return on average allocated tangible equity

21.0%

20.9%

20.0%


22.1%

18.4%


 

1

The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Barclays International











Return on average allocated tangible equity

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q4211

£m

£m

£m


£m

£m

£m

£m


£m

Attributable profit

848

953

1,348


625

1,136

783

1,300


818













£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Average allocated equity

37.6

38.0

38.1


39.9

40.1

38.2

36.0


33.8

Average goodwill and intangibles

(0.8)

(0.9)

(1.0)


(1.0)

(1.0)

(0.9)

(0.9)


(0.9)

Average allocated tangible equity

36.8

37.1

37.1


38.9

39.1

37.3

35.1


32.9












Return on average allocated tangible equity

9.2%

10.3%

14.5%


6.4%

11.6%

8.4%

14.8%


9.9%












 

 

 

 

 

Corporate and Investment Bank










Return on average allocated tangible equity

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q4211

£m

£m

£m


£m

£m

£m

£m


£m

Attributable profit

721

798

1,209


454

1,015

579

1,316


695













£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Average allocated equity

31.5

31.8

31.8


33.7

34.0

32.7

30.8


28.7

Average goodwill and intangibles

-

-

-


-

-

-

-


-

Average allocated tangible equity

31.5

31.8

31.8


33.7

34.0

32.7

30.8


28.7












Return on average allocated tangible equity

9.2%

10.0%

15.2%


5.4%

11.9%

7.1%

17.1%


9.7%

 

Consumer, Cards and Payments










Return on average allocated tangible equity

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q421

£m

£m

£m


£m

£m

£m

£m


£m

Attributable profit/(loss)

127

155

139


171

121

204

(16)


123












£bn

£bn

£bn


£bn

£bn

£bn

£bn


£bn

Average allocated equity

6.1

6.2

6.3


6.2

6.1

5.5

5.2


5.1

Average goodwill and intangibles

(0.8)

(0.9)

(1.0)


(1.0)

(1.0)

(0.9)

(0.9)


(0.9)

Average allocated tangible equity

5.3

5.3

5.3


5.2

5.1

4.6

4.3


4.2












Return on average allocated tangible equity

9.6%

11.8%

10.5%


13.0%

9.5%

17.8%

(1.5)%


11.7%












 

1                     

The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Tangible net asset value per share

As at 30.09.23

As at 31.12.22

As at 30.09.22


£m

£m

£m

Total equity excluding non-controlling interests

68,315

68,292

67,034

Other equity instruments

(11,857)

(13,284)

(13,270)

Goodwill and intangibles

(8,265)

(8,239)

(8,371)

Tangible shareholders' equity attributable to ordinary shareholders of the parent

48,193

46,769

45,393






m

m

m

Shares in issue

15,239

15,871

15,888






p

p

p

Tangible net asset value per share

316

295

286

 

Performance measures excluding the impact of the Over-issuance of Securities












Barclays Group

Q323

Q223

Q123


Q422

Q322

Q222

Q122


Q4211


£m

£m

£m


£m

£m

£m

£m


£m

Statutory attributable profit

1,274

1,328

1,783


1,036

1,512

1,071

1,404


1,079

Net impact of the Over-issuance of Securities

-

-

-


-

29

(341)

(240)


(38)

Attributable profit excluding the impact of the Over-issuance of Securities

1,274

1,328

1,783


1,036

1,483

1,412

1,644


1,117












Average tangible shareholders' equity (£bn)

46.5

46.7

47.6


46.7

48.6

49.0

48.8


48.0

Return on average tangible shareholders' equity excluding the impact of the Over-issuance of Securities

11.0%

11.4%

15.0%


8.9%

12.2%

11.5%

13.5%


9.3%

 

1

The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Reconciliation of financial results excluding the impact of the Over-issuance of Securities in the prior year

 

Three months ended

30.09.23


30.09.22




Statutory


Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities



 

£m


£m

£m

£m


% change

Income








Corporate and Investment Bank

3,082


2,821

(466)

3,287


(6)

of which:








FICC

1,147


1,546

-

1,546


(26)

Equities

675


246

(466)

712


(5)

Global Markets

1,822


1,792

(466)

2,258


(19)









Total operating expenses








Corporate and Investment Bank

(2,008)


(1,545)

503

(2,048)


2









Nine months ended

30.09.23


30.09.22




Statutory


Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities



 

£m


£m

£m

£m


% change

Income








Corporate and Investment Bank

10,220


10,792

292

10,500


(3)

of which:








FICC

4,121


4,719

-

4,719


(13)

Equities

1,942


2,709

292

2,417


(20)

Global Markets

6,063


7,428

292

7,136


(15)









Total operating expenses








Corporate and Investment Bank

(6,192)


(6,968)

(966)

(6,002)


(3)

 

Notable Items





Nine months ended 30.09.23

Nine months ended 30.09.22

£m

Profit before tax

Attributable profit

Profit before tax

Attributable profit

Statutory

6,447

4,385

                    5,702

                    3,987

Net impact from the Over-issuance of Securities

-

-

(674)

(552)

Customer remediation costs on legacy loan portfolios

-

-

(282)

(228)

Settlements in principle in respect of industry-wide

devices investigations by SEC and CFTC

-

-

(165)

(165)

Other litigation and conduct

(32)

(13)

(105)

(98)

Structural cost actions

(119)

(91)

(78)

(64)

Re-measurement of UK DTAs

-

-

-

(346)

Excluding the impact of notable items

6,598

4,489

7,006

5,440







Three months ended 30.09.23

Three months ended 30.09.22

£m

Profit before tax

Attributable profit

Profit before tax

Attributable profit

Statutory

1,885

1,274

                    1,969

                    1,512

Net impact from the Over-issuance of Securities

-

-

37

29

Customer remediation costs on legacy loan portfolios

-

-

(101)

(81)

Other litigation and conduct

-

9

(63)

(60)

Structural cost actions

(50)

(38)

(22)

(18)

Excluding the impact of notable items

1,935

1,303

2,118

1,642

 

The Group's management believes that the non-IFRS performance measures excluding notable items, included in the table above, provide valuable information to enable users of the financial statements to assess the performance of the Group. The notable items are separately identified within the Group's results disclosures which, when excluded from Barclays' statutory financials, provide an underlying profit and loss performance of the Group and enables consistent comparison of performance from one period to another.

 

These non-IFRS performance measures excluding notable items are included as a reference point only and are not incorporated within any of the key financial metrics used in our Group Targets, which are measured on a statutory basis.

 

Shareholder Information

 










Results timetable1




Date





2023 Full Year Results and Annual Report




20 February 2024

























% Change3

Exchange rates2

30.09.23

30.06.23

31.12.22

30.09.22


30.06.23

31.12.22

30.09.22

Period end - USD/GBP

1.22

1.27

1.21

1.12


(4)%

1%

9%

YTD average - USD/GBP

1.24

1.23

1.24

1.26


1%

-

(2)%

3 month average - USD/GBP

1.27

1.25

1.17

1.18


2%

9%

8%

Period end - EUR/GBP

1.15

1.16

1.13

1.14


(1)%

2%

1%

YTD average - EUR/GBP

1.15

1.14

1.17

1.18


1%

(2)%

(3)%

3 month average - EUR/GBP

1.16

1.15

1.15

1.17


1%

1%

(1)%










Share price data









Barclays PLC (p)

158.94

153.38

158.52

144.30





Barclays PLC number of shares (m)4

15,239

15,556

15,871

15,888























For further information please contact


















Investor relations

Media relations

Marina Shchukina +44 (0) 20 7116 2526

Tom Hoskin +44 (0) 20 7116 4755





















More information on Barclays can be found on our website: home.barclays










Registered office









1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.










Registrar









Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.



Tel: +44 (0)371 384 2055 (UK and international telephone number)5.












American Depositary Receipts (ADRs)









EQ Shareowner Services

P.O. Box 64504

St. Paul, MN 55164-0504

United States of America

shareowneronline.com








Toll Free Number: +1 800-990-1135









Outside the US +1 651-453-2128


















Delivery of ADR certificates and overnight mail









EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA.

 

1

Note that these dates are provisional and subject to change.

2

The average rates shown above are derived from daily spot rates during the year.

3

The change is the impact to GBP reported information.

4

The number of shares of 15,239m as at 30 September 2023 is different from the 15,220m referenced in the 2 October 2023 announcement entitled "Transaction in Own Shares" because the share buyback transactions executed on 28 and 29 September 2023 did not settle until 2 and 3 October 2023 respectively.

5

Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings